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Abstract 

HIV infection is a known co-factor in the increased incidence of sepsis which is a 
state of endotoxin tolerance (ET). During ET, with repeated exposure to non­
pyrogenic amounts of endotoxin, there is an imbalance in pro- and anti­
inflammatory cytokines when re-challenged with the endotoxin. We hypothesized 
that the ET state would be exacerbated in the HIV-1 transgenic (HIV-1Tg) rat, 
which has 7 of the HIV-1 viral proteins expressed without viral replication. Upon 
measuring the gene-expression we found that IL-1a, !L-1J3, IFN-y, Cc12, 7 and 9 
were upregulated to a greater extent in the spleen and cytokine receptors were 
modulated differently in the brain of the HIV-1Tg rat versus control in the ET state, 
indicating that the continuous presence of HIV-1 viral proteins alters the cytokine­
and chemokine-profiles in the ET state. The expression of the j..I-opioid receptor 
(MOR), which is known to mediate the rewarding and anti- nociceptive properties 
of its ligands like morphine, is modulated by inflammatory cytokines. As MOR is 
unregulated in the HIV-1Tg rat we hypothesized that rewarding properties of 
morphine may be enhanced in HIV-1Tg rat and tested this hypothesis using the 
conditioned preference placement (CPP) test. After developing a CPP, the rats 
with morphine paired with the white compartment of the CPP apparatus failed to 
show extinction after greater than 2 weeks of testing. Following extinction in rats 
with morphine paired with the black chamber, both drug and stress failed to induce 
a reinstatement of CPP. The morphine CPP procedure may sometimes result in 
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other forms of behavioural plasticity that does not conform to the 
Pavlovian/memory model. 
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Introduction 
HIV-l infection and the HIV transgenic rat model 
Following infection with the Human Immunodeficiency Virus-1 (HIV-1), a 
burst of virus replication disseminates the virus to lymphoid organs. A 
robust cellular and humoral immune response ensues within a few weeks 
but the virus invariably escapes immune containment and results in chronic 
persistent infection leading to advancing clinical disease(Fauci 1996). The 
pathogenesis of HIV-1 infection results from the actions of HIV-1 viral 
proteins, including the envelope glycoprotein 120 (gp120), on targeted cells, 
such as macrophages and T-Iymphocytes (Clapham and McKnight 2001; 
Cicala, Arthos et al. 2002; Jiang and Aiken 2006). Since 1996, highly active 
antiretroviral therapy, or HAART-has produced dramatic improvements in 
health and longevity for HIV-infected individuals (Palella, Delaney et al. 
1998). HARRT regimens typically include two nucleoside (or nucleotide) 
analogue reverse transcriptase inhibitors (NRTls) and either a protease 
inhibitor or a non-nucleoside reverse-transcriptase inhibitor (NNRTI) (Ellis, 
Calero et al. 2009). By inhibiting HIV replication at several stages in the 
viral life cycle, HAART markedly reduces the likelihood that drug resistance 
will develop (Ellis, Calero et al. 2009). Judicious use of antiretroviral 
therapy, by suppressing viral replication and partially restoring immune 
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function, can prevent opportunistic infections and markedly prolong survival 
with HIV (Ellis, Calero et aL 2009). However, HAART drugs are limited in 
their capacity to enter the CNS and other organs that are protected by tight 
endothelial barriers. Thus, in this post-HAART era, the clinical challenge is 
to identify the biological and physiological changes that occur due to the 
persistent presence of HIV-1 viral proteins in the host even when active 
viral replication is arrested (Jones and Perelson 2005; Vigano, Trabattoni et 
ai. 2006). 
Some HIV-1 viral proteins have been shown to affect the inflammatory 
response by altering the production of cytokines. For example, the HIV-1 
Tat protein can alter the LPS-induced production of IFN-(3 and IL-6 in blood 
monocytes/macrophages(Yim HC 2009), and HIV-1 Vpr suppresses IL-12 
production in human monocytes (Mirani M 2002). However, the effects of 
HIV-1 viral proteins on immune function during a state of ET has not been 
examined. 
The HIV-1 transgenic (HIV-1Tg) rat model was developed with a functional 
deletion of the gag and pol genes in the HIV-1 genome. It is, however, 
under the control of the viral promoter and expresses seven of the nine HIV 
genes (Reid, Sadowska et al. 2001). Thus. there is no active viral 
replication but viral proteins are expressed in various organs' immune cells 
and in the circulation (Reid. Sadowska et al. 2001). Clinical signs include 
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wasting, mild to severe skin lesions, opaque cataracts, neurological signs, 
and respiratory difficulty (Reid, Sadowska et at. 2001). While it is well-
known that HIV-1 affects the host target cells and causes the many 
pathological manifestations of AIDS, it has also been shown gp 120 and 
Tat, the HIV-1 viral proteins, can cause organ dysfunction independently 
(Klotman and Notkins 1996; Bruggeman, Dikman et at. 1997; van Maanen 
and Sutton 2003). It has been shown that, like HIV-1 infected patients, the 
HIV-1Tg rat is immunodeficient. LPS-induced leukocyte-endotheiiai . 
adhesion (LEA) is greatly attenuated in the HIV-1Tg rat(Chang 2007). In 
addition, the HIV-1Tg rat shows signs of wasting and dies at a younger age 
even though there is no growth retardation and no sign of anorexia 
throughout its life span(Peng, Vigorito et al. 2010). It has been shown that 
prior to manifesting signs of wasting the expression of HIV viral proteins in 
various tissues changes(Peng, Vigorito et al. 2010). Reid and colleagues 
showed that spliced and unspliced viral transcripts were expressed in the 
spleen of HIV-1Tg rats(Reid, Sadowska et at 2001). Peng and colleagues 
showed that in the HIV-1Tg rats at 10-11 months of age the expression of 
Tat, gp120, nef, and vif viral protiens decreased significantly in the spleen 
compared to 2-3 months of age, but increased Significantly in the spinal cord and 
cerebellum(Peng, Vigorito et al. 2010). These rats also have decreased 
alveolar macrophage expression of granulocyte-macrophage colony­
11 

stimulating factor and impaired bacterial phagocytosis. which may increase 
their susceptibility to pneumonia(Joshi, Raynor et al. 2008}. The HIV-1Tg 
rat has also been shown to develop neurological deficits including motor 
I (Reid, Sadowska et al. 2001) and cognitive deficits(Lashomb, Vigorito et al. 
2009). Brain M incorporation and other markers of M metabolism are ! upregulated in HIV-1 Tg rats (Basselin, Ramadan et al. 2011; Lund, Lucero 
I 
I 
et al. 2011). The HIV-1Tg rat model, thus, exhibits some of the 
characteristics of HIV-1 infected patients given HMRT (Chang, Beltran etI 
i j 
 al. 2007; Peng, Vigorito et al. 2010; Basselin, Ramadan et al. 2011; Lund, 

, 
Lucero et al. 2011). 
I, 
I Role ofInflammatory cytokines in HIV-l infection andI progression to AIDS I 
I In HIV-1 infected individuals and persons with AIDS the immune system is 
I 
t 
dysfunctional at many levels. There is immunodeficiency induced due to 
1 loss of CD4-positive T helper cells (Lane, Masur et al. 1983) and I 
i hyperactivity as a result of B-cell activation (Holguin, O'Connor et al. 2004). 
t 
~ Additionally, inflammatory cytokines are modulated in HIV-1 infected I j individuals by the actions of viral proteins, mainly gp120 (Holguin, O'Connor 
I et al. 2004). Cytokine changes in HIV-1 infection have been assessed by a 
! 
I 
1 
i 12 
variety of techniques, ranging from determination of cytokine gene 
expression at the mRNA level to secretion of cytokine proteins in vivo and 
in vitro. It has been shown that as soon as 5 days after detection of 
viremia, (at least 100 HIV RNA copies/mI). cytokines IFNa and IL-15 were 
elevated, followed by TNFa, CXCL 10, and IFNV. and then by IL-12 (Stacey, Norris 
et al. 2009). Increased mRNA and protein levels of anti-inflammatory cytokine, IL­
10. are detected rather late in HIV infection. after the increased expression of 
proinflammatory cytokines(Stacey, Norris et a!. 2009). Location of cytokine 
production in the very early phase of HIV infection is most likely local. However, 
after the virus disseminates, cytokines are produced by distant sites such as distal 
lymph nodes, gut-associated lymphoid tissue and genital draining(Haase 2010). 
Changes in cytokine levels in HIV-1 infected persons can affect the function 
of the immune system, and have the potential to directly impact the course 
of HIV disease by enhancing or suppressing H IV replication (Breen 2002). 
In particular, the balance between the pro-inflammatory cytokines IL 1~, IL­
6, and TNF-a, which up-regulate HIV expression, and IL-10, which can act 
both as an anti-inflammatory cytokine and a B-cell stimulatory factor, may 
play an important role in the progression to AIDS (Chen, Zhou et al. 2005). 
PrO-inflammatory cytokines, IL 1-~, TNF-a, and IL-6, were shown to be up­
regulated in spinal cord glia activated by gp-120 (Breen 2002). It has been 
shown that a non-pyrogenic dose of LPS induces a 7 to 38 fold increase in 
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IL-1~ and TNF-a in HIV-1Tgrats and only 1 to 2 fold increase in these 
cytokines in the F344 rats, whereas there was no significant difference 
observed in IL-10 levels in HIV-1Tg rats vs. F344 rats, suggesting that there 
is an imbalance of pro- vs. anti-inflammatory cytokine regulation with LPS 
administration in HIV infection (Chen, Zhou et al. 2005). 
Endotoxin Tolerance 
The bacterial endotoxin, lippopolysccharide (LPS), is a well-characterized 
glycolipid component of the gram-negative bacterial cell wall and is a potent 
inducer of the inflammatory response in animals (Schletter, Heine et al. 
1995). LPS is model molecule commonly used to study the inHarnmatory 
responses caused by infection with bacteria, especially the induction and 
actions of pro-inflammatory cytokines, including tumor necrosis factor-alpha 
(TNF-a), interleukin (IL)-1~, IL-6, and anti-inflammatory cytokines like IL-10 
(Turnbull and Rivier 1999). LPS and other Gram-negative bacterial 
pathogens primarily engage the Toll like receptor-4 (TLR-4), which employs 
signaling through two distinct adaptors - Myeloid differentation 88 (MyD88) 
and TIR domain-containing adapter protein inducing IFN-~(TRIF) (Biswas 
1 	 and Lopez-Collazo 2009). The MyD88 pathway leads to the activation of 
t 	 transcription factor NFKB which in the initial phase activates pro-
inflammatory genes like TNFa, IL 1~, IL6 and IL 12~. The TRIF pathway I j 
1 
t 	 14 j
, 
1 
1
, 
leads to the activation of transcription factors IRF3 and STAT1 which 
I 
t 
subsequently activate IFNJ3 and interferon-inducible genes like CCl5 and 
f 
i CXCl10, which ultimately leads to the induction of anti-inflammatory genes ~ 
I 
~ 
like Il-10 (Biswas and lopez-Collazo 2009). These pathways are 
temporally segregated, MyD88 leads to the early activation of NFKB and the 
j TRIF pathway is implicated in mediating the late-phase activation of NFKB 
1 
I (Biswas and lopez-Collazo 2009). Crosstalk between the MyD88 and TRIF 
I 
I 
I 
! pathways exists and there are various negative regulators for each pathway 
I that are modulated by one of both of these pathways forming a complex 
I signaling network (Biswas and lopez-Collazo 2009). It is the balance 
between the production of pro-inflammatory cytokines and chemokines and 
I the subsequent production of anti-inflammatory cytokines that initiates a 
robust inflammatory response in the innate immune system cells like 
macro pages and monocytes (Biswas and lopez-Collazo 2009). A tight 
regulation of the initial production of the pro-inflammatory cytokines is 
required to protect against going into septic shock, an example of this 
regulatory mechanism is Endotoxin Tolerance (Biswas and lopez-Collazo 
2009). Exposure of the innate immune cells to minute amounts of 
endotoxin, like lPS, makes them refractory to subsequent endotoxin 
challenge establishing endotoxin tolerance. At a molecular level, during 
endotoxin tolerance, there is a decrease in the production of pro­
15 
inflammatory cytokines with an endotoxin re-challenge when compared to 
the initial increase in pro-inflammatory cytokines with first exposure to the 
endotoxin. And an increase in anti-inflammatory cytokines is observed with 
an endotoxin re-challenge when compared to the initial anti-inflammatory 
cytokines levels observed with first exposure to the endotoxin (Biswas and 
Lopez-Collazo 2009). A clinical example of endotoxin tolerance is sepsis. 
Following a systemic bacterial infection a dysregulated innate immune 
response leads to sepsis. Sepsis is biphasic with the first phase being of 
overt inflammation and a subsequent phase of "immunoconpromise", in 
which the innate immune cells show a endotoxin tolerant phenotype 
(Biswas 2009). The overt inflammation phase is called the systemic 
inflammatory response syndrome (SIRS) in which there is an 
overproduction of pro-inflammatory cytokines and organ failure{Adib­
Conquy and Cava ilion 2009). The immunocomprornised or 'endotoxin­
tolerant' state of spesi~ is termed compensatory anti-inflammatory response 
syndrome or CARS. This is the state and is clinically correlated most with 
secondary infections and mortality (Adib-Conquy and Cavaillon 2009). 
Although, these two states of sepsis have been reported to be concomitant 
by some researchers, the failure of anti-inflammatory therapies in sepsis 
and the fact that most mortality is associated with patients in the 
immunocompromised state, supports the biphasic nature of spesis(Biswas 
16 

and Lopez-Collazo 2009). In sepsis patients blood monocytes have the 
expression of proinflammatory cytokines like TNFa, IL-6, IL-1a, IL-1 band 
IL-12, significantly diminished upon ex vivo LPS challenge as compared to 
that of monocytes from healthy individuals (Munoz, Carlet et al. 1991; 
Monneret, Venet et al. 2008; Draisma, Pickkers et al. 2009). At the same 
time, upregulated expression of anti-inflammatory cytokines like IL-10, 
TGFb and IL-1 RA were reported in these cells (Cavaillon, Adrie et al. 2005; 
Monneret, Venet et al. 2008; Draisma, Pickkers et ai. 2009). 
Clinical Relevance ofEndotoxin Tolerance with Respect to HIV-l 
Infection 
There is an association between chronic HIV infection and elevated plasma 
endotoxin levels. Innate immune responses, which are dysregulated in ET, 
are also altered in HIV infection (Lester, Yao et al. 2008). There is 
increased expression and responsiveness of TLR in chronic HIV-1 infection. 
The mRNA expression of TLR 6 , 7 and 8 was elevated in chronic 
untreated HIV-1 infection and TLR 2,3 and 4 were additionally elevated in 
advanced disease (CD4 cell count < 200 cells/ml) in peripheral blood 
mononuclear cells(Lester, Yao et al. 2008). This TLR expression alteration 
may perpetuate innate immune dysfunction and activation that underlies 
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HIV pathogenesis (Lester, Vao et al. 2008). The cytokines/chemokines 
modulated during ET playa role in HIV infection, replication (not applicable 
for our model) and pathogenesis. Toll-like receptor 4 (TLR4) mediates 
gram-negative bacteria activated signaling and significant changes in this 
receptor's level is directly correlated with HIV infection (Lester, Vao et al. 
2008). TNF-a upregulation leads to HIV-induced cytotoxicity (Westendorp, 
Shatrov et al. 1995). Enhanced levels of Ccl2 in HIV-1 patients have been 
associated with HIV-1-associated dementia (Ansari, Heiken et ai. 2007). 
The Center for Disease Control (CDC) has identified HIV-1 infection as a 
major reason for the increase in incidence of sepsis (Angus, Linde-Zwirble 
et al. 2001). Opportunistic infections are a common feature in HIV-1 
positive patients, who have a compromised immune status (Levy 1998). ET 
leads to a similar immunosuppressed state. Identifying the mechanism by 
which ET affects an already immune-compromised system, observed with 
HIV-1 infection, could provide valuable information of clinical relevance. 
We hypothesized that the continuous presence of HIV-1 viral proteins alters 
the systemic immune response to bacterial endotoxins in terms of pro- and 
anti-inflammatory cytokine and chemokine expression, and that this altered 
immune response is exacerbated when the animal is in an ET state. 
Specifically, we hypothesized that the production of pro-inflammatory 
cytokines is diminished and anti-inflammatory cytokine production is 
18 
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I 
i 
I 
J 
I 
1 enhanced in the HIV-1Tg rat rendered endotoxin tolerant. To test this I 
! 
~ 
hypothesis, we examined the expression of an array of cytokines, 
I 
I 
chemokines, and their receptors in the serum, spleen, and brain of an 
endotoxin tolerant HIV-1Tg rat model in response to an LPS challenge. !! 
1 
I Morphine, and HIV infection Morphine is a derivative of opium, which is the juice of the opium poppy, 
I Papver somniferum. Morphine was first used and still is used as a pain-
I 
J killer in the management of diseases like cancer and acquired 
immunodeficiency syndrome (AIDS). When ingested, morphine can 
produce a feeling of euphoria and a state of well-being; this makes it a 
1 
i popular choice to be used as a recreation drug which is often abused. 
1 
cl 
i Approximately one third of the AIDS cases in the USA have been 
1 suggested to be related to the use of injected addictive drugs, such as 
I 
I 
1 morphine, making it a very significant co-factor in contracting human 
immunodeficiency virus type 1 (HIV-1) (Steffen, Blattler et al. 2001; 
Banerjee, Strazza et al. 2011). The reason for higher addiction rates to 
I 
1 
! 
morphine among HIV-1 infected individuals may be to over-come the 
1 depression and stress due to the disease or that morphine addicted 
persons may be more prone to risky sexual behaviour and in tum be more 1 
i 
prone to contracting HIV-1 infection (Beyrer 2007; Shetty 2011). 
1 
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i 
Conversely, HIV-1 infected persons are more prone to be addicted to 
morphine than the general population(Koulierakis, Gnardellis et al. 2000). 
Thus, there may exist a bidirectional and synergistic relationship between 
morphine abuse and the contraction of HIV-1 infection. 
Most research in this field has been directed towards studying the effects of 
drugs of abuse on HIV-1 viral infection and there is a paucity of studies 
exploring the possible bidirectional feedback that may exist between drugs 
of abuse and the persistence of viral proteins in HIV infection. 
Immunosuppression associated with Morphine Abuse and HIV 
infection 
Chronic morphine abuse has been well-documented to result in severe 
immune consequences. Pulmonary infections, caused by Mycobacterium, 
Staphylococcus, Streptococcus, Haemophilus, and other bacteria, are 
among the most common diagnoses of opiate abusers (Risdahl. Khanna et 
al. 1998). Other serious diseases caused by microbial pathogens in opiate 
users are AIDS (HIV), endocarditis (Staphylococcus, Enterococcus, 
Pseudomonas, Klebsiella, Serratia, and Candida), abscesses and cellulitis 
(StaphylococclJs, Streptococcus, Haemophilus, Enterobacter, 
Pseudomonas, Klebsiella, Clostridium, Candida, and others), hepatitis A, S, 
20 

and C (hepatitis A, S, and C viruses), sexually transmitted diseases, and 
skeletal infections (Staphylococcus and Pseudomonas) (Risdahl, Khanna et 
al. 1998). Studies concerning the effects of addictive drugs on 
immunocompetence have taken on a greater urgency with the onset and 
explosive expansion of the worldwide pandemic of AIDS caused by HIV, 
which results in the collapse of the immune system, rendering individuals 
highly susceptible to opportunistic microorganisms that normally would not 
cause life-threatening infections. Intravenous (Lv.) drug abusers become 
highly susceptible to HIV not only because of contaminated shared needles 
but also because of associated immunosuppression caused by opioids 
(Friedman, Om pad et al. 2003). Studies over the past few decades have 
shown that opiates markedly affect many immune responses, both in vivo 
and in vitro, in animal models such as rodents and mice, and even in 
monkeys and swine, including altered resistance following challenge 
infection with a microorganism. Morphine is known to supress the 
functionality of both innate and adaptive immune cells (Friedman and 
Eisenstein 2004; Dinda, Gitman et al. 2005; Roy, Wang et al. 2006). 
Morphine suppresses pro-inflammatory signal in dendritic cells, 
macrophage activation and phagocitosis(Wang, Ma et al. 2011; Wang, Ye 
et al. 2011). TLR signalling and production of pro-inflammatory cytokines is 
significantly modulated by morphine(Roy, Ninkovic et al. 2011) . 
21 
Several opiate receptors have been identified on cells of the nervous 
system and immune system of animals and humans, with lJ, K, and V 
subtypes predominating (Cabral 2006). These classical opiate receptors, 
similar to cannabinoid receptors, are G-protein-coupled seven 
transmembrane molecules. Opiates directly ligate lJand Vopiate receptors 
as well as non-classical opiate-like receptors on immune cells, and also 
bind to similar receptors on CNS cells. Opioids have been reported to have 
direct (House, Thomas et ai. 1996; McCarthy, Wetzel et ai. 2001) as well as 
indirect effects (Chang, Wu et al. 1998; Roy, Charboneau et al. 2001) on 
the immune system through the mediation of lJ, K, and 60pioid receptors as 
well as non-classical opioid-Iike receptors. MOR ligands can mimick 
chemoattractants (direct effect) (Simpkins, Taylor et al. 1984; Grimm, Ben­
Baruch et al. 1998; Grimm, Ben-Baruch et al. 1998) and can inhibit 
chemotaxis of cytokines and chemokines by (indirect effect) (Grimm, Ben­
Baruch et al. 1998). Peterson and colleagues proposed that MOR ligands 
"can be viewed as cytokines operating both within somatic immune tissues 
and the CNS" (Peterson, Molitor et al. 1998). Treating astroglial cells with 
IL-1~ increased MOR mRNA expression by 70-80% (Ruzicka, Thompson et 
al. 1996); simultaneous treatment with IL-1 a and IL-1 ~ increased MOR 
expression in primary cell cultures of human brain microvesicular 
endothelial cells (Vidal, Patel et al. 1998). These studies were among the 
22 

first to report the link between cytokines and MOR and opened up the field 
of neuroimmunology, showing that the immune system interacts with the 
CNS by modulating the expression of neurotransmitter receptors which 
mediate the effects of addictive substances. CCR5 and CXCR4 are the 
main HIV-1 co-receptors, which cooperate sequentially with CD4 to 
facilitate virus entry into target cells. A possible mechanism for increased 
susceptibility to HIV-1 with morphine abuse is provided by studies that show 
that the expression of CCR5 and CXCR4 in CD3{+) iymphoblasts and 
CD14{+) monocytes is increased 3-5 folds by DAMGO, a selective MOR 
agonist{Guo, Li et al. 2002; Wang, Barke et al. 2005). By enhancing 
CXCR4 and CCR5 expression, opioids increase HIV-1 infection(Steele, 
Henderson et al. 2003). Additionally, it has been shown by several studies 
that morphine and other MOR agonists increase the expression of CCR5 
and CXCR4 on glial cells{Miyagi, Chuang et al. 2000; Steele, Henderson et 
al. 2003; Mahajan. Aalinkeel et al. 2005; Mahajan, Schwartz et al. 2005; 
Burbassi, Aloyo et al. 2008; Happel, Steele et al. 2008; Bokhari, Yao et al. 
2009). It has been postulated that morphine induces the expression of 
these chemokine receptors by the modulation of cytokines , like IL-12 and 
TNF-a, which are known to stimulate chemokine receptor expression(Hu, 
Chao et al. 2000). 
23 

Mechanisms ofmorphine immunomodulation 
Although the specific mechanisms of the changes induced in the immune 
system by morphine are not fully understood, the initial step is mediated 
through the MOR, which is expressed on immune cells including 
macrophages and lymphocytes as well as in the central nervous system 
(CNS) (House, Thomas et al. 1996; Chang, Wu et al. 1998; McCarthy, 
Wetzel et al. 2001; Roy, Charboneau et al. 2001). Expression of the MOR 
can be modulated in both the immune system and neuronal cells by various 
cytokines. IL-1 was the first cytokine that was demonstrated to increase the 
mRNA level of MOR in endothelial cells (Vidal, Patel et al. 1998). IL4 was 
shown to induce MOR transcripts in human primary blood cells, immune 
cell lines, and dendritic cells (Kraus, Borner et al. 2001). IL6 induced only 
induced MOR mRNA and not the ~ opioid receptor in a human 
neuroblastoma cell line (Borner, Kraus et al. 2004). TNF-a was shown to 
induce MOR gene transcription in primary human T lymphocytes, Raji B 
cells, U937 monocytes, primary human polymorphonuclear leukocytes, and 
mature dendritic cells (Kraus, Borner et al. 2003). Morphine also exerts an 
indirect effect on immune cells through MORs located in the CNS. Several 
stUdies indicate that morphine acts on central MORs and activates the 
hypothalamic-pituitary-adrenal (HPA) axis resulting in the release of 
glucocorticoids from the adrenal cortex (Gottlieb, Schroff et al. 1981). 
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These studies indicate that cytokines and chemokines modulate the effects 
of MOR ligands like morphine but these MOR ligands also have an effect 
on the function of these immune molecules. Studies indicate that that 
morphine use increases the progression of HIV-1 infection to AIDS through 
its interaction with cytokines, chemokines, and their receptors (McCarthy, 
Wetzel et al. 2001; Hahn, Jagwani et al. 2010; EI-Hage, Dever et al. 2011). 
Morphine phosphorylates CXCR1 and CXCR2 receptors and induces 
heterogeneous desensitization of these receptors thus inhibiting the 
migration of CXC1 and CXC2 to their receptors (Grimm, Ben-Baruch et al. 
1998). On the other hand, chemokines and their receptors, which are also 
HIV-1 co-receptors, have been implicated in the neuropathogenesis of HIV­
1 infections. Astrocytoma cell line U8? treated with morphine showed 
significant down-regulation of IL-8 gene expression, whereas expression of 
the IL-8 receptor CXCR2 was reciprocally up-regulated (Mahajan, Schwartz 
et al. 2002). Furthermore, treatment of normal human astrocyte (NHAs) 
with morphine suppressed IL-8 and macrophage-inflammatory protein-113 
gene expression, whereas expression of their receptor genes, CCR3 and 
CCR5, was simultaneously enhanced (Mahajan, Schwartz et at 2002). 
These morphine-induced effects on U8? and NHA cells were reversed by 
the MOR antagonist 13 -funaltrexamine. Morphine also enhanced the 
constitutive expression of the MOR on astroglial cells (Mahajan, Schwartz 
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et al. 2002). These results suggest that morphine has the potential to 
increase HIV-1 co-receptor expression, promoting viral trafficking and 
binding on infected cells as well as increasing CNS disease progression, 
and increasing susceptibility to HIV infection. Opioid receptor selective 
agonists have been shown to modulateinfection by HIV-1 and HTLV-1 by in 
vitro syncytia formation (Nyland, Specter et al. 1998). Morphine promoted 
the survival of CEMx174 cells in early stages of simian immunodeficiency 
virus (SIV) infection in vitro, a modei system that has been used to study 
HIV infection. Cell cycle analysis indicated that, in response to the 
treatment with morphine, SIV-infected cells were accumulated in the C1 
phase. The investigators suggested that the calcium-PKC-MAPK cascade 
was involved in morphine prolonged survival of cells in the early stages of 
virus infection(U, Hao et al. 2004). In an HIV-1 transactivator of 
transcription (TAT)-transgenice mouse model morphine was shown to have 
a major inhibitory effect on mitogen-induced IL-2 production. This decrease 
of IL-2 production correlated with reduced percentages of CD4+ and CD8+ 
splenic lymphocytes (Garza, Prakash et al. 1996), These studies indicate 
that morphine affects the responsiveness of immune cells to infectious 
agents and their interaction with the HIV in vitro. 
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Upregulation ofthe Mu-opioid receptor in HIV-l Tg rat brain 
may enhance propensity for addiction 
The persistent presence of HIV viral proteins may contribute to the 
dysregulation of both the dopaminergic and opioidergic pathways, and may 
lead to reward and addictive behaviors. Expression of the dopamine 
receptor (01R) is increased in HIV-1Tg rats and methamphetamine-induced 
behavior sensitization is more profound in the H IV -1 T 9 rats. H IV -1 T 9 rats 
showed less behavior sensitization to nicotine in comparison to F344 
(Midde, Gomez et al. 2011). Both these studies suggest that that the 
presence of HIV proteins in the HIV-1Tg rat altered its sensitivity to an 
addictive drug. The JJ opioid receptor (MOR) which is expressed in the 
central nervous system cells and in the immune system cells, may 
contribute to the mediation of the analgesic and rewarding actions of 
opioids such as morphine (Fowler and Fraser 1994; Chang, Beltran et al. 
2007). Exposure of peritoneal macrophages of F344 rats to serum from 
HIV-1Tg induced MOR-upreguJation, which was abolished by addition of 
gp120 antibody to the serum (Chang. Beltran et al. 2007). HIV-1Tg rats 
when treated with morphine showed significantly longer tail flick latencies 
compared to control F344 rats, indicating that there is an increased potency 
of morphine's anti-nociceptive properties in the HIV-1Tg rats (Chang 2011). 
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As MOR is up-regulated in the HIV-1Tg rat and it has also been shown that 
the anti-nociceptive properties of morphine are enhanced in the HIV-1Tg rat 
we wanted to investigate if the rewarding and addictive properties of 
morphine are also enhanced in the HIV-1Tg rat. 
Craving for and relapse to a drug after a period of abstinence are the salient 
features of addiction (Koob and Nestler 1997). In drug addiction there is a 
very significant behavioral change in that that the addict has decreased 
abiiity to control drug seeking behaviour(Kaiivas and Voikow 2005). in 
laboratory animals relapse following abstinence is modeled using the 
reinstatement procedure. Animals are first trained to associate a behavior 
(self administration) or a place (CPP) with a drug. Then a period of 
extinction is introduced whereby the behavior or place is no longer followed 
by the drug and responding returns to baseline. The effects of various 
stimuli are then introduced to look for evidence of the return of responding 
or reinstatement. Reinstatement of drug seeking behavior, or relapse, is 
caused in the laboratory by re-introduction to the drug (drug-primed) , 
exposure to stress (stress-primed) or re-introduction of the stimuli which 
was previously associated with drug use (cue-primed) (Shalev, Grimm et al. 
2002; Kalivas 2003). Re-introduction to previous stimuli/environment 
associated with drug-use increases the urge to use drugs (Kalivas and 
Volkow 2005). These motivational properties of the conditioned stimuli 
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(associated with drug) use can persist over a very long period of time, even 
after years of abstinence the conditioned stimuli can evoke drug-re­
instatement (Kalivas and Volkow 2005). 
Conditioned Place Preference 
The conditioned place preference (CPP) is a commonly used test in 
animals to measure the rewarding/addictive properties of a drug by 
measuring the motivational salience of drug-paired cues, by means of 
classical conditioning (Tzschentke 1998; Tzschentke 2007). In the CPP 
procedure, there is repeated pairing of an unconditioned stimuli {test-drug} 
with a conditioned stimulus (distinct environment) and of a control vehicle 
with another environment (Tzschentke 1998). The drug-paired environment 
gains motivational significance and the animal shows approach behavior to 
that environment and a preference for it over the vehicle-paired 
environment in the drug-free state(Tzschentke 1998). After the 
establishment of a CPP the animal is given free access to both 
environments for several sessions in the absence of the drug until the 
animal ceases to display a statistically significant preference to the drug­
paired environment (extinction)(Tzschentke 1998). Extinction is evidence 
that the preference is a learned association(Rutten K 2011 }. Extinguished 
associations are not permanently lost and can be re-expressed. After 
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extinction exposure to a drug-prime or to a stressor can be studied for their 
ability to re-instate the extinguished CPP response (Tzschentke 1998). 
Reinstatement procedures cause the previous associations to be re­
expressed. It has been clearly demonstrated that stress causes a greater 
propensity towards drug-seeking behavior, which causes a greater chance 
to become addicted (Donovan, Padin-Rivera et al. 2001; Ouimette, Coolhart 
et al. 2007) and puts the subject at a greater risk for relapse (Dewart, Frank 
et ai. 2006). This phenomenon has been noted in animals as well. in rats, 
an increase in locomotor activity (behaviour response to drug) was noted in 
morphine-treated rats pre-expose to mild repeated foot-shock(Leyton and 
Stewart 1990). Exposure to foot-shock also re-instated morphine-induced 
CPP in rats (Wang, Luo et al. 2000). 
Conditioned Place Preference Apparatus 
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Morphine-induced CPP has been studied using F344 rats (Gagin, Kook et 
al. 1997; Grakalic, Schindler et al. 2006; Davis, Roma et al. 2007). There 
exists a strain-based sensitivity to morphine-induced CPP; F344 rats are 
more sensitive to morphine and acquire morphine-induced CPP at lower 
doses and with fewer conditioning cycles than Lewis rats (Davis, Roma et 
al.2007). In this study we have hypothesized that the HIV-1Tg animal 
would be more sensitive to the morphine associated cues than the F344 rat 
due to the up-regulation of MOR in the presence of HIV-1 proteins. As the 
unbiased CPP procedure used in the present study is not favorable for 
establishing differences in rates of acquisition due to potential "ceiling" 
effects (Roma and Riley 2005). We investigated the difference between 
HIV-1Tg and control, F344 rats, in the vulnerability to re-expression of 
motivational salience of morphine paired cues by reinstatement procedures. 
A greater motivational salience of morphine paired cues would be expected 
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to result in greater reinstatement of a preference for the drug-paired 
environment. In addition we investigated the effectiveness of a nonspecific 
stressor (uncontrollable foot-shock) in establishing a reinstatement effect. 
32 

Summary and significance ofwork: 
There were an estimated 48,100 new HIV infections in 2009, per the CDC 
(Prejean, Song et al. 2011) and the estimated number of people living 
world-wide with HIV was 43 million in 2010, per the world health 
organization {WHO}. The CDC has identified the increasing rate of HIV 
infection as a major reason for the increased incidence of sepsis, in which 
the patients are in a state of ET. During ET there is an imbalance of pro­
and anti-inflammatory cytokine expression leading to an abnormal immune 
response when re-exposed to endotoxins like LPS. We hypothesized that 
the persistence of viral proteins alters the systemic immune response to 
bacterial endotoxins in terms of pro- and anti-inflammatory cytokine and 
chemokine expression, and that this altered immune response is 
exacerbated in an endotoxin tolerant state. Specifically, we hypothesized 
that the production of pro-inflammatory cytokines is diminished and anti­
inflammatory cytokine production is enhanced. Taking advantage of the 
HIV-1Tg rat model, we examined the effects of LPS induced endotoxin 
tolerance by measuring the gene expression of 84 cytokines, chemokines 
and their receptors in the brain and spleen in response to an LPS 
challenge. This research will help better understand the mechanisms 
underlying the increased susceptibility of HIV-1 patients to spesis. It 
provides information on specific inflammatory cytokine, chemokine and their 
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receptors' genes that are modulated during ET in the HIV-1Tg rat. This 
information can be further used to study the inflammatory cytokine, 
chemokine and their receptors' gene-profiles in other models including 
humans. 
Another aspect of the project was to examine the effect of morphine 
associated motivational salience in the HIV-1Tg rat. Inflammatory cytokines 
are known to modulate MOR expression and the progression of HIV-1 
infection to AIDS. Also, MOR is upreguiated in the HIV-1Tg rat (Chang, 
Beltran et al. 2007). We hypothesized that the HIV-1Tg animal would be 
more sensitive to the morphine associated cues than the F344 rat due to 
the up-regulation of MOR in the presence of HIV-1 proteins and altered 
cytokine profiles. We investigated the difference between HIV-1Tg and 
control, F344 rats, in terms of extinction of CPP and the vulnerability to re­
expression of motivational salience of morphine paired cues by 
reinstatement procedures. A greater motivational salience of morphine 
paired cues would be expected to result in greater resistance to extinction 
(Rutten K 2011) and/or greater reinstatement of a preference for the drug­
paired environment. In addition we investigated the effectiveness of a 
nonspecific stressor (uncontrollable foot-shock) in establishing a 
reinstatement effect. This research provides salient information on 
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exploring the bi-directional link that may exist between morphine-abuse and 
HIV-1. 
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Materials and Methods 
Animals used for gene expression and protein analysis 
Adolescent male Fisher 344/NHsd Sprague-Dawley background HIV-1 
transgenic (HIV -1Tg) rats and age-matched Fisher INHsd 344 (F344) 
control rats were purchased from Harlan Laboratories (Indianapolis, IN), 
and were delivered on post-natal day 28. The animals were group-housed 
immediately upon arrival, and stayed in group cages during the experiment. 
The animals were maintained in an environment of controlled temperature 
(21-22° C) on a 12-h Iightl12-h dark illumination cycle, with lights-on set at 
7:00 AM. Food and tap water were provided ad libitum. The experimental 
protocol was approved by the Institutional Animal Care and Use Committee 
(IACUe) at Seton Hall University, South Orange, NJ. 
Lipopolysaccharide (LPS) administration for gene expression 
and protein analysis 
Dosing solutions of LPS were prepared in saline. In our preliminary studies 
using Harlan Sprague Dawley rats, we found that two intraperitoneal (i.p) 
injections with a non-pyrogenic dose (250 IJg/kg ea) of LPS, administered 9­
12 hrs apart, was the lowest dosage regimen that would cause endotoxin 
tolerance and inhibit the production of IL-1J,i, TNF-a, and IL-6 in response to 
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a subsequent challenge with a significantly higher dosage of lPS [1, 4, 8, 
16, or 32 mg/kg] (data not shown). In this study, HIV-1Tg and F344 rats (n 
=12 ea, 19-20 wks old) were randomly assigned to four experimental 
groups (n =3 animals/group). At 8:00 AM and 5:00 PM on Day 1, Groups 1 
and 2 received two i.p. injections of 250 ~g/kg lPS each (ll); Groups 3 and 
4 received two i.p. injections of saline (SS). At 8:00 AM on Day 2, Group 1 
received one Lp. injection with 5 mg/kg lPS (ll+l); Group 2 received one 
Lp. injection with saline (ll+S); Group 3 received one i.p. injection with 5 
mg/kg lPS (SS+L); and Group 4 received one i.p. injection with saline 
(SS+S). The dosage of 5 mg/kg for the subsequent lPS injection was 
chosen based on previous studies using the HIV-1Tg rat model (Chen, 
Zhou et aJ. 2005). Two hours following the last injection, the brains, 
spleens, and blood were collected for RNA, protein, and serum preparation. 
Protein extraction from the brain and spleen 
Protein extracts were prepared from approximately 100 mg of brain and 
spleen tissue in a Tris lysis buffer containing 20 mM Tris, pH 7.5, 1 mM 
EDTA,1 mM EGTA, and 1M NaF (all from Sigma Aldrich, St. louis, MO), 
and 1 tablet of Protease Inhibitor (Roche, Mannheim, Germany). The 
tissues were disrupted using the Branson Sonifier 250 (\f\NR, Radnor, PAl 
with 15 sec bursts, a duty cycle setting of 40% (0.4 sec bursVO.6 sec 
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pause), and an output of 4. The concentration of protein from each of the 
tissue types was determined using the ProStain assay kit (Active Motif, 
Carlsbad, CA), by re-suspending the lyophilized dye in methanol and dilute 
this stock solution. This stock solution was added to each well of the 
microplate followed by adding the sample. Fluorescence intenSity was 
measured against a BSA standard curve with the Spectra Max Gemini 
(Molecular Devices, Sunnyvale, CA). 
Measurement ofinflammatory cytokines 
Protein levels of IL-1j3, KC/GRO, IL-4, IL-5, TNF-a. IFN-y. and IL-13 were 
determined in undiluted serum and in extracts from 200 I-Ig of brain and 
spleen using a 96-well inflammatory cytokine kit [MesoScale Discovery 
(MSD), Gaithersberg, MDl. The MSD plate is prepared per the kit 
instructions 
(http://www.mesoscale.com/CatalogSystemWeb/Documents/RaC 96_ welL 
US.pdf) , the sample or calibrator are added, followed by the addition of 
detection antibody solution, followed by the read buffer. Measurement of 
electrochemiluminescent signal intensity was determined on the SECTOR 
2400 instrument (MesoScale Discovery, Gaithersberg, MD). Calibrator 
solutions were diluted 4-fold over a concentration range of 40,000 pg/mL to 
9.8 pg/mL. 
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RNA isolation and preparation ofeDNA 
Total RNA was extracted from brain and spleen homogenates using 
TRIZOL (Invitrogen, Carlsbad, CAl. The extracts were then treated with 
Ambion® TURBO DNA-freeTM (Ambion, Austin, TX) to remove 
contaminating DNA, and harvested using a RNeasy mini kit (Qiagen, 
Valencia, CAl. The tissues were disrupted and the lysate was 
homogenized in the buffer, the Iysates were centrifuged the supernantant 
was removed, 70% ethanol was added to the cleared lysate, sample was 
transfered to an RNeasy spin column and centrifuged, wash buffer was 
added followed by centrifugation 
(http://www.qiagen.com/products/rnastabilizationpurification/rneasysystem/r 
neasyminLaspX#T abs=t2). RNA quality and quantity were assessed using 
a Nanodrop spectrophotometer. Equal amounts of RNA from each sample 
were then converted into first-strand cDNA using a RT2 First Strand Kit (SA 
Biosciences, Frederick, MD). The genomic DNA elmination mixture (with 
RNA sample and kit reagents) and the reverse transcription cocktail was 
prepared using the kit's instructions 
(http://www.sabiosciences.com/rtpcrproductlHTML/330401.html). The 2 
are mixed and incubated at 42°C for 15 min afterwhich the reaction is 
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stopped by heating at 95°C for 5 minutes and First Strand cDNA Synthesis 
Reaction is obtained. 
Real-time peR array 
Detection and quantification of gene expression were performed using a 
Rat Inflammatory Cytokines and Receptors PCR Array and RT2 SYBR 
Green Fluorescin qPCR Master (SA Biosciences, Frederick, MD) according 
to the manufacturer's instructions 
(http://www.sabiosciences.com/manuals/pcrarraywhitepaper.pdf).This kit 
was chosen because it includes diverse genes important in immune 
responses, including genes encoding CC chemokines (n = 16), CXC 
chemokines (n =9), interleukin cytokines (n =14), other cytokines (n =11), 
chemokine receptors (n =15), and cytokine receptors (n =11), as well as 
other genes involved in the inflammatory response (n =8). 
Real-time PCR was performed using an ABI Prism 7900HT Fast 
Detection System (Applied Biosystems, Foster, CA). Each 10 IJL reaction 
was performed in a 384-well format PCR array. The PCR mix was 
denatured at 95° C for 10 min before the first PCR cycle. The thermocycler 
parameters were 95° C for 10 min, followed by 40 cycles at 95° C for 15 s, 
and 60° C for 1 min. 
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peR array data analysis 
In order to be able to compare different PCR array results, the threshold 
and baseline values were set manually, according to the manufacturer's 
instructions, and the resulting threshold cycle value (CT) data were 
uploaded into the data analysis template on the manufacturer's website 
(http://www.sabiosciences.com/pcr/arrayanalysis.php). RNA expression of 
each gene was normalized using five housekeeping genes as controls. The 
relative expression of each gene, compared with the expression in the 
control group, was calculated on the website using the MCT method. A 
difference was considered significant at p < 0.05. In the expression studies, 
a gene was considered differentially regulated if the difference was >2-fold 
compared with the control, and markedly differentially regulated if the 
difference was >10-fold (DeRisi, Penland et al. 1996; DeRisi, Iyer et al. 
1997; Linde, Sandhagen et al. 1999; Sudarsanam, Iyer et al. 2000; 
Well mann, Thieblemont et al. 2000; Montgomery and Daum 2009). Each 
reported value represents the mean increase or decrease of mRNA 
expression relative to the levels for the controls from three biological 
replicates. 
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Statistical analysis o[Protein and Gene expression after LPS 
treatment 
Inflammatory cytokine protein level data in this study are presented as the 
mean ± SO. Statistical analysis was done using Graphpad Prism 5.0. 
Differences among treatment groups were analyzed by a one-way ANOVA, 
followed by a Newman-Keuls post hoc test. The difference in the basal 
levels of cytokineslchemokines in the brain, spleen, and serum between 
F344 and HIV-1Tg rats was determined using the Student's t-test. 
Animals used [or CPP 
Male HIV-1 transgenic (HIV -1Tg) rats and age-matched male Fisher /NHsd 
344 (F344) control rats were purchased from Harlan Laboratories 
(Indianapolis, IN). Animals were group housed 4-5 per cage in ventilated 
cages with a 12/12 hour day/night cycles (lights on at 7 AM) in a 
temperature controlled environment (21-22°C) with food and tap water 
available ad libitum. The animals were always tested in the light phase of 
the day/night cycle (9AM-2PM). Animals were acclimatized for 
approximately 2 months and handled for 3 consecutive days for 1-2 minutes 
each before beginning testing on them. The animals were approximately 3 
months old (HIV-1Tg: 193-227g; F344: 228-277 g) when the experiment 
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was conducted on them. The experimental protocol was approved by the 
Institutional Animal Care and Use Committee (IACUC) at Seton Hall 
University, South Orange, NJ. 
Drug 
Morphine sulfate was obtained from (Sigma, St. Louis, MO). 
Morphine was administered intra peritoneally (i.p) as a 3.5 mg/kg dosage in 
the conditioning phase and as a 1 mg/kg or a 3.5 mg/kg dosage in the 
reinstatement phase. 
cpp apparatus 
A commercially available CPP apparatus (MED Associates, East 
Fairfield, VT) was used. The apparatus consisted of an 18cm x 20cm white 
chamber with a grid floor and an18cm x 20cm black chamber with a rail 
floor connected by a side passage; this design ensures that the animal is 
always visible to the camera. This side passage in the middle of the two 
chambers had two doors on each chamber wall; the doors could be closed 
to isolate each chamber. The animal movement and time spent in each 
chamber was detected by an infrared camera (Stoelting ANY-maze, Wood 
Dale, IL). ANY-maze software (Stoelting ANY-maze, Wood Dale, IL) was 
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used to analyse the camera recordings to measure time spent in the each 
chambers. 
Foot shock administration 
A custom foot-shock administrating apparatus box 40 cm w x 40 cm 
d x 35 cm h, connected to an animal shocker, was purchased from Stoelting 
ANY-maze (Wood dale, IL). The apparatus was set to deliver foot shock to 
an animal in it intermittently, for 15 minutes, with an amplitude of 0.5 mA, 
and a 0.5 s duration, (off period 10-70 s, mean 40 s). 
CPP, extinction and re-instatement procedure 
There were five phases for this experiment. During the 
preconditioning phase (1 day), the animals were placed in the side passage 
with the door of the chambers open and allowed to explore the entire box 
for"15 minutes. In the conditioning phase (6 days), an approximately equal 
number of animals of each strain (HIV-1Tg and F344) were assigned to 
each type of chamber (white or black) as the morphine paired side. The 
animals were injected with 3.5 mg/kg morphine (dose based on pilot data) 
every other day and placed in the pre-assigned morphine-paired side and 
on the next day were injected with equivalent volume of saline and placed 
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in the saline-paired side, with the chamber door closed for 30 minutes. In 
the post-conditioning phase (1 day) the rats received no drug or saline and 
were placed in the side passage and allowed free access to the entire box 
for 15 minutes. For the first 8 days of the extinction procedure, the animals 
were put in the side passage and given free access to the box for 30 
minutes. After the first 8 days of extinction (Extinction 1) testing there was 
no evidence of extinction so the extinction procedure was altered in the 
hope of accelerating extinction. Evidence suggests that handling and 
transportation cues contribute to contextual conditioning (Bevins. McPhee 
et al. 2000). thus during extinction day 9 through day 17 (Extinction 2) the 
extinction procedure was repeated twice daily for 15 minutes per session 
with an average interval of 2 hours and 17 minutes between the 2 sessions, 
to increase the number of exposures to the transportation cues without 
changing the duration of exposure to the context (30 minutes total). 
Dividing the extinction procedure into two separate sessions also permitted 
for the opportunity of spontaneous recovery (see Discussion). Moreover. 
the HIV-1Tg rats received 3 additional days of extinction (see Results). 
Following extinction the rats in each strain were distributed equally to either 
be assigned in the drug-induced reinstatement group or in the stress­
induced reinstatement group. The rats in the drug-induced reinstatement 
group received 1 mg/kg morphine on reinstatement day 1 and were given 
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free access to the entire box for 15 minutes; on re-instatement day 2 the 
rats were given 3.5 mg/kg morphine and were given free access to the 
entire box for 15 minutes. The rats in the stress-induced re-instatement 
group on day 2 of the re-instatement phase were administered foot-shock 
for 15 minutes and subsequently put in the CPP apparatus and given free 
access to the entire box for 15 minutes. 
The movement of the rats in the CPP apparatus was tracked by the 
ANY-maze camera and software in all phases. The experiment was carried 
out daily. 
Statistical Analysis 
The means and standard deviations of the absolute time spent by 
animals (for each strain) in each chamber were calculated in all phases of 
the experiment. Inspection of the extinction data indicated that the chamber 
that was paired with morphine had a substantial effect on preference 
behaviour. To evaluate the effect of color/flooring of the chambers on the 
acquisition and extinction of CPP the data was analysed with color of the 
morphine-paired chamber as a factor. Careful inspection of the data also 
revealed systematic changes in preference within a test session suggesting 
that there was habituation of exploratory behaviour over time. To test this 
hypothesis the extinction sessions were separated into segments of five­
46 

minutes. Analysis of variance (AN OVA) was used to study the interaction 
of strain (F344, HIV-1Tg), phase (pre-conditioning, post-conditioning, 
extinction 1 and2, and/or reinstatement), morphine-paired chamber, drug 
(morphine-paired, saline-paired). A value of p :::;;0.05 was considered 
statistically significant difference. 
All analyses were done using the statistical software SPSS 
Statistics 17.0 IBM). 
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Results 

Cytokine and chemokine protein expression in the serum, brain, 

and spleen ofHIV-1 Tg rats during endotoxin tolerance (ET) 

The protein levels of IL-1~, KC/GRO, IL-4, IL-5, TNF-a, IFN-y, and IL-13 
were determined in the brain, spleen, and sera of HIV-1Tg and F344 rats 
rendered ET (LL), then challenged with either LPS (LL +L) or saline (LL +S), 
using an electrochemiluminescent (MSD) assay (Table 1-3). Saline-treated 
animals were used as controls (SS+S). There was no difference in the 
basal levels (SS+S group levels) of the cytokines/chemokines measured in 
the serum in the two strains of animals (Table 1). In the F344 serum, the 
levels of the pro-inflammatory cytokine, IFN-y, and the anti-inflammatory 
cytokines, IL-4 and IL-13, in the single exposure group (SS+L) were 
significantly greater than in the control group (SS+S), and significantly less 
in the ET group (LL +L) than in the single exposure group (SS+L). In the 
HIV-1Tg serum, the levels of the pro-inflammatory cytokines, JL-1~, TNF-a, 
and IFN-y, and the anti-inflammatory cytokines. IL-4 and IL-13, in the single 
exposure group (SS+L) were significantly higher than in the control group 
(SS+S), and significantly lower in the ET group (LL +L) than in the single 
exposure group (SS+L) [fable 1]. 
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Table 1: Cytokine/Chemokine Profiles in F344 and HIV-1Tg Rat Serum 
Cytokines and Chemo~nes in the Serum with LPS Treatment 
Prolein IP9Im1H±SO) 
L·l~ KCJffiO L-4 L-5 Ttfll FN-y L·13 
F344 TtK11!rrmS 
i rRerW.i11 00ta rRerW.i14 ~5 focIlr·~ _gamma 111013 
SS+S 83.~t21.3) l~~f89·n ~~±O.6l 116·~:t23·n 42.7{i6.1) 35~±721 27~±U) 
SS+l 272.1(±145.1) 715U;±2779.Sr 1~~t1.~ 348.7(t202.4) 7531.~±~.O) 138.~t46.2)tt 42.3(i9.sr 
tl+S 81.~!4'.4) 7&1.~±846.6} 10.~!511j 103.~t3261 51~±12.4) i~±lR61 22.~±1.11 
ll+l 125.1(:t23.~ ~i680.6j 11.1!t1.1rA 210·~~·n &il~t25.5) 61~t1l9)AA 26.~±2.1r 
; i 
i 
L·l~ KCGID L-4 L·5 Ttfll fN.r L·13 
HIV -iTg Tmrms 
~01001a nl04 tnlKif15 focIlr·. _gamma n!eIWil13 
-
"~_"~W_"~ ~" ~~,.-
SS+S 85~±31.~ 19J7.~±97a91 10.7(±2.0) 154.7(±83.6) 45~±11.41 67~±32.21 26.~iO.5) 
SS+l J7.~±n.sr ~±l61.~ttt 14.~±2.5) 2~.~±37.3l 257!f92Ur 12U:t114)* 36~i6.6)' 
ll+S 47.~±7.4) 327.~±110.5) 8.~±l.41 29]{±34.3L 42~±7.~1 18.~±24.9) 22.~±1.11 
ll+l 128.~oru 3051~t121~7}'AA 11.~±O.8)AA lm.l(±121.1) 113.~i51.srlA 71.1(i9.W 27,~±4~A 
.. P<O.05, ..* P<O.01, *** P<O.OO1 greater than SS+S control; 1\ P<O.05, 1\1\ P<O.01, I\AA P<O.OO1 less than SS+L 
F344 n=12, 3 in each group; HIV-1Tg n=12. 3 in each group 
The basal levels of IL-4 and TNF-a in the F344 rat brain, and IL-4, IL-5, 

and TNF-a in the HIV1-Tg brain, were not detectable by 

electrochemiluminescent (MSD) assay. The basal levels of 
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cytokines/chemokines that were detectable in the brain were similar in both 
strains of animals (Table 2). An LPS challenge dose (SS+L and LL+L) did 
not significantly alter any of the cytokine/chemokine levels in the F344 rat 
brain (Table 2). However, in the HIV-'ITg rat brain, the levels of the pro­
inflammatory cytokines, IL-113 and IFN-y, were significantly higher in the 
SS+L group versus the control. The level of the pro-inflammatory cytokine, 
IFN-y, was significantly lower in the LL +L group compared to the SS+L 
group (Table 2). 
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Table 2: Cytokine/Chemokine Profiles in the F344 and HIV-1Tg Rat Brain 
Cytokines and Chemokines in the Brain with lPS Treatrnent 
Proteillpghnr-SD) 
F344 
l·1p KCJGRO l-4 loS N-a FN-y l·13 
tieIWilllwJta nteret.m4 ttrerm5 
TIm~ 
m·afiIa ~gamma Werm13 
SStS 42.2(f8.8) 74.~±23.3) N) $.~±) NO 15.~±7.5l 4.~i1.8) 
SS+l 178.~±162.1) 1325.~±1431.3) l3.~ 102.~±61.1) 30.9 : 2O~±11.9) 4.B1±3.1) 
lltS 59.11±26·3) 112.6(f35.6) 3.4 74.7 If) 14.1(±7.0) 6.~±1.4) 
LLtl 207.~±133.0) 10li~±685.6) 2.~±1.~ 141.~f98.3) NO 21.~±6.~ 5.~±2.3) 
HW·1Tg 
l·lp KCJGRO l-4 l·5 TNF-a FN-y l·13 
tieIWilllwJta Werm4 ttrerm5 
TlIIlOfrem~ 
fa:1Of •afiIa rereron gamma 
11.7(±5.2) 
i1ereukil13 
5.l(fOA)SStS 37.~i17.l) 125.~f87.a) N) N) NO 
.5SS+L 361.7(±104.' 2991.31±491.~1i 9.~±3.1) 164~±35.3) 47.11±1(5)* 9.~±411 
LLtS $.~±15.1l 12B.l(±61.6) N) NO NO 8.~±5.~ 4.~i1.4) 
Ll+L 208.~±167.4) 131~±10391)A a.ll±1.6) 18121±50·0) 27.3 24.31±14.5jA 7.~±3.71 
• P<O.05, •• P<O.OI, .... P<O.OOI greateT SS+S control;" P<O.05, AI' P<O.OI, """ P<O.OOI less than SS+L 
F344 n=12, 3 in each group; HIV-Hg n=12, 3 in each group 
The basal level of TNF-a was not detectable in the spleen of either the 
F344 or HIV1-Tg rats (Table 3). There was no Significant difference in the 
basal levels of any of the cytokines/chemokines that were detectable in the 
spleen of the F344 and HIV-1Tg rats, with the exception of IFN-y, which 
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was significantly greater in the F344 rat spleen compared to that in the HIV­
1Tg rat spleen (Table 3). In the F344 spleen, the levels of the pro­
inflammatory cytokines, IL-1 J3 and IFN-y. and the anti-inflammatory 
cytokines, IL-4 and IL-13. in the single exposure group (SS+L) were 
significantly higher than in the control. In the F344 rats, the levels of the 
pro-inflammatory cytokines, IL-1 J3 and IFN-y, and the anti-inflammatory 
cytokine, IL-4, were significantly lower in the spleen of the LL +L group 
compared to the single exposure group (SS+L). In the HIV-1Tg spleen, the 
levels of the pro-in'l~ammatory cytokines, IL-1 J3 and IFN-y, and the anti­
inflammatory cytokine. IL-4, were significantly higher in the single exposure 
group (SS+L) and in the endotoxin tolerant group (LL +L) compared to the 
control. In the LL+L group of HIV-1Tg rats, the pro-inflammatory cytokines, 
IL-1 J3 and IFN-y. and the anti-inflammatory cytokine, IL-4, were significantly 
lower than in the single exposure (SS+L) group (Table 3). 
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Table 3: Cytokine/Chemokine Profiles in the F344 and HIV-1Tg Rat Spleen 
C~okines and Chemo~nes in ~e Spleen with LPS Treabnent 
Protei1lPW~tSDI 
L·l~ KClffiO L4 LoS Ttf-o FN-y L·13 
F344 TIJ11a'a~ 
liIWIlllxta hIM4 nlR5 B:ir.~ _gJIIIma trterWil13 
SS+S 18J2.~i6l5.7) 264.7(±l22n 6.~±3.3) l19.~±2flO) Nl 34.~±13.6) 3.7(±2.3) 
SS+l 1ml71±1115.4J* 2OC65~±11a=a1) 171±16.0)tt 34t4(±83.9r OO~±2752.3) 203.3I±11 ~tt 22.1liiOr 
ll+S m~±440.6) [6.~±al5.0) 6·~±5·n 1~.~±28.8) Nl 32.~±28.1) 3.~±3.0) 
ll+l 7~±1!m9f 1181a7(~) 21 c,••" 246.~±19.4) m~±19.6) l05.~±45.O)tA 14~±6.1) 
, 
i , 
L·l~ KumO L4 L·5 Ttf-o FN-y L·13 
H~·1Tg Tma~ 
hIeIMIllxta ~mm4 h1e!M15 m·o ~MlIl!J.llnma nIeIWil13 
SS+S 1274.~±1223) ~1.1(±187·n 3.~±1.4) 107.7(±33.0) Nl m~±4.8) O.~±O.7) 
SS+l 19951~±4023A}tt 2i1~±l114~tt 41.~±5.Jr 395.~±93,3)tt 2755..±1596.0) ~.~±83~tt 32.0\±4Jj 
ll+S r<67.1(±1675.4) 961.~±~.1) 7.~±2.0} 178.~±571) Nl 19.~±26) 6.~±6.41 
ll+l 11443.11±74OO)*A 12754,~±116113IA 27~±12.6jA 239.~±77.1IA 356.1(±149.4) 151~±17~tA 19.~±11.41 
,. P<O.05, .. P<O.OI, ••• P<O.OOI greater than SS+S control; " P<O.05, J\A P<O.Ol, N\A P<O.OOI less than SS+L 
F344 n=12. 3 in each group; HIV·1Tg n=12, 3 in each group 
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Expression profiles ofcytokines, cytokine-receptors, and other 
inflammatory molecules in the brain and spleen ofthe HIV-l Tg 
rat following LPS treatment 
The gene expression profiles of an array of cytokines, cytokine receptors, 
and other inflammatory molecules were determined in the brain and spleen 
of the three LPS treatment groups (SS+L, LL +S, and LL +L) and compared 
to the control group (SS+S) of both the HIV-1Tg and F344 rats (Figure-1). 
In the F344 and HIV-1Tg rat brain, the level of the pro-inflammatory 
cytokine, IL-1J3, was elevated in the LL+L (>9 fold) and SS+L (>4 fold) 
groups. The level of the anti-inflammatory cytokine, IL-10, was elevated in 
the brain of both the SS+L (>3 fold) and LL +L (>2 fold) groups in the F344 
rats, but only in the brain of the SS+L (>2 fold) group in the HIV-1Tg rat 
brain (Figure-1). In the spleen of the F344 and HIV-1Tg rats, the levels of 
the pro-inflammatory cytokines, IL-1a, IL-1J3, were elevated in both the 
SS+L (>10 fold) and LL +L (>5 fold) groups. The levels of the pro­
inflammatory cytokines, IFN-y and TNF-a, were increased in the SS+L 
group (>6 fold), and the anti-inflammatory cytokine, IL-10, was higher in the 
SS+L (> 5 fold) and LL+L (>7 fold) groups (Table-4). 
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Table 4: Cytokine Expression in the Brain and Spleen of F344 and HIV-1Tg Rats 
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F344 n=12, 3 in each group; HlY-1Tg n=12, 31n eachgroupEXpression profiles of 
chemokine and chemokine receptors in the brain and spleen of 
the HIV-l Tg ratfollowing LPS treatment 
The gene expression profiles of various chemokines and chemokine 
receptors were examined in the three LPS treatment groups and compared 
to the control group (SS+S) in both the HIV-1Tg and F344 rats (Figure-2). 
The gene expression of the inflammatory cc chemokines, Ccl2, Ccl3, Ccl?, 
and Cc120, and inflammatory Cxc chemokines, Cxcl1, Cxcl2, and Cxcl1 0, 
were up-regulated in the brain and spleen in the SS+L and LL +L groups of 
both the F344 and HIV-'ITg rats. The gene expression of the inflammatory 
cc chemokines, Ccl11 and Ccl24, were down-regulated in the brain of the 
LL+L group of both the F344 and HIV-1Tg rats, and in the SS+L and LL+L 
groups in the spleen of the HIV-1Tg rats. 
Ten of the 15 (10/15) chemokine receptors studied were down-regulated 
in the LL+L group of'the spleen of the F344 rats. One of 15 (1/15) and 
three of 15 (3/15) chemokine receptors were down-regulated in the LL +L 
group of the brain of the F344 and HIV-1Tg rats, respectively; ten of 15 
(10/15) and two of 15 (2/15) chemokine receptors were diminished in the 
LL+L group of the spleen of the F344 and HIV-1Tg rats (Figure-2). 
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Table 5: Chemokine Expression in the Brain and Spleen of F344 and HIV-1Tg Rats 
F344 n=12, 3 in each group; HIV-1Tg n=12, 3 in each group 
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Morphine-induced place preference 
Fourteen HIV-1Tg and 14 F344 rats were placed in the CPP apparatus and 
given free access for 15 minutes (pre-conditioning) to determine if either 
strain showed a preference for one of the chambers. As shown in Figure 1 
neither the HIV-1Tg rats nor the F344 rats showed a preference for either 
the black or white chambers in the pre-conditioning phase. After 6 sessions 
of conditioning with 3.5 mg/kg morphine, both HIV-1Tg and F344 rats 
showed a CPP (Figure 1). A Strain (F344, HIV-1 Tg) x Phase (Pre, Post) x 
Drug (Morphine-Paired, Saline-Paired) mixed ANOVA yielded a significant 
Phase x Side interaction F(1,26) =31.03, P =.000 • such that more time 
was spent in the morphine-paired side than in the saline-paired side post­
conditioning but not pre-conditioning. 
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Figure 1: Time spent in the morphine-paired and saline-paired side of the CPP 
apparatus by strain in pre-conditioning and post-conditioning phase is shown. On 
post-conditioning day animals (F344 n=14; HIV.1Tg n=14) were conditioned daily for 
15 minutes following a 3.5mg/kg morphine (i.p.) dose every other day for 6 days. The 
following day after 6 conditioning sessions, animals were given free access to entire 
apparatus and tested for CPP. 
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To counterbalance for the morphine/side pairings, the strains were divided 
so that approximately half received morphine paired with the black side and 
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the remainder received morphine paired with the white side. In addition to 
the color difference, the two sides also had different floors (grid and rail). 
Since the rats were tested under dim red-light illumination the floor was a 
much more salient cue than the color, eliminating a natural bias for the 
black chambers (Roma and Riley 2005). Nevertheless, for convenience the 
sides are referred to as black or white. The absence of a side preference 
during the 15 min pre-conditioning session suggested that the CPP 
apparatus used in this study was an unbiased apparatus. However after 
introducing the extinction procedure it was observed that there was a very 
high resistance to extinction in many animals. Inspection of the data 
indicated a stronger preference during extinction in the white-morphine 
paired animals than the black-morphine paired animals. Thus, to confirm 
that a CPP occurred in the white-paired and black-paired animals the data 
was analyzed with the counterbalancing factor (color of morphine-paired 
chamber) included as an independent variable (Figure 2). A Strain (F344, 
HIV-1Tg) x Phase (Pre, Post) x Morphine Color (Black, White) x Drug 
(Morphine-Paired. Saline-Paired) mixed ANOVA yielded a significant four 
way interaction, F(1,24) =4.59, p =.043, that was due to a greater CPP 
when morphine was paired with the white side in the F344 animals [Phase x 
Drug x Morphine Color: F(1, 12) = 7.54, P =.018] but not the HIV-1Tg rats. 
In the HIV-1Tg rats the significant CPP (Phase x Drug: F(1.12) =20.83, p = 
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.001) was not affected by the color of the morphine-paired chamber [Phase 
x Drug x Morphine Color: F(1,12) < 1, p =.784] (Figure 2). 
Figure 2: Time spent in the morphine-paired and saline-paired side of the CPP 
apparatus by strain and by color of morphine-paired chamber, in pre-conditioning 
and post-conditioning phase is shown. (F344 n=14; HIV-1Tg n=14). 
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To investigate further the effect of time on the development of CPP we 
analysed the data in segments of 5-minutes. Figure 3 shows the pre­
conditioning and post-conditioning results separated into three 5-minute 
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time segments. The rats were again divided in tenns of the side that was 
paired with the drug (color of morphine-paired chamber). When the pre­
conditioning data were analysed, no statistically significant effects were 
observed. However, the post-conditioning data shows clear changes in 
preference over the three, 5-minute periods. A Strain (F344, HIV-1Tg) x 
Phase (Pre, Post) x Morphine Color (Black. White) x Drug (Morphine­
Paired, Saline-Paired) mixed ANOVA confinned a 4- way interaction 
F(2,48) =4.27, p =.02. Generally, the rats engaged in considerable 
exploratory behaviour often crossing between chambers, but as time 
passed rats explored less and spent more time on the morphine-paired 
side. This can be seen in the black-paired and white-paired HIV-1Tg 
groups (bottom graph). Although this pattern of increasing preference over 
time was not seen in the black-paired F344 group it was very pronounced in 
the white-paired F344 rats (top graph). When the animals were first placed 
in the CPP apparatus they explored and might have spent more time 
exploring in the preferred sides, but as the exploratory behaviour habituates 
the time spent in the preferred side increases even more. The data 
suggests that the F344 rats that experienced morphine paired with the 
white side had the strongest preference for the morphine-paired side 
(Figure 3). 
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Figure 3: Time spent in the morphine-paired and saline-paired side of the CPP 
apparatus by strain and by color of morphine-paired chamber separated into three 5­
minute time segments, in pre-conditioning and post-conditioning phase is shown. 
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Extinction 
To test for extinction (no difference in time spent in the morphine-paired 
side and saline-paired side) animals were given free access to the both 
chambers for 30 minutes per day for 8 days (Extinction 1) and for 2 
sessions of 15 minutes per day thereafter (Extinction 2a and 2b). 
The time spent in the morphine-paired side in 5-minute time segments for 
two phases of extinction is shown in Figure 4. A score of 150 indicates 
equal time spent in the black and white chambers per time segment (no 
preference); a score greater than 150 indicates a preference for the 
morphine-paired side. The average across all days for each extinction 
phase is plotted in order to show the high resistance to extinction in the rats 
that experienced morphine paired with the white chamber and to 
demonstrate the observed within-session changes in preference. We 
hypothesize that the within-session increase in preference is due to 
habituation of exploratory behaviour in the presence of a highly preferred 
white chamber. Evidence consistent with this habituation interpretation is 
provided in Extinction 2 where spontaneous recovery of exploratory 
behaviour was observed as a result of the delay between Extinction 2a and 
2b (Figure 4). These results suggest that the rats had a natural preference 
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for the white side that was not evident in the preconditioning phase, but 
when paired with morphine it became a much stronger preference that was 
highly resistant to extinction. 
Figure 4: Extinction phase: To test for extinction, animals (F344 (n=14), HIV-1Tg 
(n=14» were given free access to the entire apparatus for 30 mlns (F344: 8 days, 
HIV-1Tg: 8 days) everyday (Extinction 1) and then for 2 fifteen min sessions/day 
(F344:9 days, HIV-1Tg: 13 days) (Extinction 2a and 2b) until all animals reach 
extinction. Average time spent in the morphine-paired side by strain and by color of 
morphine-paired chamber separated into three 5-minute time segments (group 
means) in the 2 phases of extinction (Extinction 1 and Extinction 2 (a and b» is 
shown. 
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If habituation of exploratory behaviour contributes to the increasing 
preference over time in the CPP test, as hypothesized here, then the 
preference at the beginning of Extinction 2b (minutes 16-20) should be less 
than the preference observed at the end of Extinction 2a (minutes 10-15) 
because the delay causes the spontaneous recovery of exploratory 
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behaviour. This is the pattern seen in the Extinction 2 data of the white­
morphine paired groups that are plotted in Figure 4. Note that this drop in 
preference between minutes 10-15 and minutes 16-20 is not seen in 
Extinction 1 since there was no delay imposed between these time 
segments to allow for spontaneous recovery of exploratory behaviour. To 
confirm these observations a spontaneous recovery score was calculated 
for all rats by subtracting the time spent on the morphine-paired side during 
the fourth time segment (minutes 16-20) from the time spent on the 
morphine-paired side during third time segment (minutes 11-15). A positive 
score indicates spontaneous recovery, whereas a negative score indicates 
continued habituation. To facilitate statistical analysis of Extinction 1 (which 
had 8 days) and Extinction 2 (which had 9 days), the last day of extinction 2 
was omitted. The data was then analyzed with a Strain (2) x Morphine 
Color (2) x Extinction Phase (2) by Days (8) mixed ANOVA. The white­
morphine paired and black-morphine paired HIV-1Tg and F344 groups 
averaged across days for the two extinctions sessions are shown in Figure 
5. Spontaneous recovery was observed in the white-morphine paired 
groups (right panel) in Extinction 2, when a delay was present, but not in 
Extinction 1 when there was no delay. These observations were supported 
by a significant main effect of Extinction Phase, F(1 ,24) =17.3, P =.000. A 
significant main effect of color of morphine-paired chamber, F(1 ,24) = 6,14, 
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p = .021 , supports the impression that spontaneous recovery was greater in 
the white-morphine paired groups than the black-morphine paired groups. 
There was no significant effect of days. The results also suggest that 
spontaneous recovery was greater in the F344 rats than the HIV-1Tg rats, 
but the main effect of strain fell short of significance, F(1, 24) =3.29, p =.08 
and strain did not interact with any other factor. 
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Figure 5: Spontaneous Recovery Score- The time spent on the morphine-paired side 
during the 4th time segment (minutes 16-20) was subtracted from the time spent on 
the morphine-paired side during third time segment (minutes 11-15). A positive 
score indicates spontaneous recovery, whereas a negative score indicates 
continued habituation. The results for the white-morphine paired and black-
morphine paired HIV-1 and F344 groups averaged across days for the two 
extinctions sessions are shown below. To facilitate statistical analysis of Extinction 
1 (which had 8 days) and Extinction 2 (which had 9 days), the last day of extinction 2 
was omitted. (F344 n=14; HIV-1Tg n=14) 
Extinction Phase 
These pattern of data suggest that during a CPP test there are several 
factors that influence overall behaviour: a conditioned place preference, a 
natural preference (when present), and the elicitation of exploratory 
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behaviour that interacts with the conditioned and natural preferences. The 
impact of the two preferences on performance differs across a session as 
exploratory behaviour undergoes habituation, with the stronger preference 
dominating control of behaviour later in a session as the rats begin to "settle 
into" one chamber. Whereas a strong natural preference for one side may 
obscure a more modest conditioned place preference later in a session, the 
conditioned place preference may have a greater contributing role in overall 
performance earlier in a session when exploratory behaviour is at its 
maximum. We suggest that the strong preference for the white chamber in 
the rats that received the white side paired with morphine is a result of an 
enhanced natural preference for the white side rather than a result of the 
summation of a conditioned place preference with a natural preference. If 
the latter was true, then preference in the first 5 minutes of an extinction 
session (when a modest CPP is having its greatest impact on performance) 
should decline over days as the CPP undergoes extinction, whereas the 
preference later in a session (which reflects the stronger natural preference) 
should persist over days. However, if morphine induced the enhancement 
of a natural preference that is resistant to extinction, then the observed 
preference should be seen at all time intervals across all days with no 
evidence of extinction. The time in the morphine- and saline-paired sides of 
the F344 animals that received morphine paired with the white side is 
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shown over days for two of the six 5-minute time segments in Figure 6. A 
preference for the morphine-paired side in the first 5 minutes (top panels) is 
observed that does not change over days in Extinction 1, [Effect of Drug: 
F(1 ,5) = 63.62, P =.000; Drug x Days: F(7, 35) < 1, n.s.], or in Extinction 2 
[Effect of Drug: F(1 ,5) = 28.27, P =.003; Drug x Days: F(8, 40) = 1.34, P = 
.251]. Thus, there is no evidence of extinction over days, even when just 
the first 5 minutes, when a CPP is likely to have its greatest impact, are 
examined. By the fourth time segment (minutes 16-20) of Extinction 1 the 
preference for the morphine-paired time is even greater (bottom, left panel) 
as exploratory behaviour begins to habituate. However, during Extinction 2, 
when the 16 - 20 minute time segment was preceded by a break, the 
preference is again reduced as exploratory behaviour spontaneously 
recovers. Yet there is still no indication of a decreased preference for the 
morphine-paired side over days, [Drug x Days: F(8, 40) = 1.73, P =.121]. 
71 

Figure 6: The time spent in the morphine- and saline-paired sides over days of the F344 animals that 
received morphine paired with the white side. The Extinction 1 graphs are shown on the left side and 
Extinction 2 are shown on the right. Data from only 2 of the 6 time segments are shown The top 
graphs show the first time segment (minutes 1 - 5) and the lower graphs show the fourth time 
segment (minutes 16-20). During Extinction 2 the 16-20 minute time segment was preceded by a break 
from the previous session to allow for spontaneous recovery of exploratory behavior. (F344 rats with 
morphine paired with white side n=7). 
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The same pattern is also seen in the HIV-1Tg rats (Figure 7). 
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Figure 7: The time spent in the morphine- and saline-paired sides over days of the 
HIV-1Tg animals that received morphine paired with the white side. The Extinction 1 
graphs are shown on the left side and Extinction 2 are shown on the right. Data 
from only 2 of the 6 time segments are shown. The top graphs show the first time 
segment (minutes 1 - 5) and the lower graphs show the fourth time segment 
(minutes 16-20). During Extinction 2 the 16-20 minute time segment was preceded 
by a break from the previous session to allow for spontaneous recovery of 
exploratory behavior. (HIV-1Tg rats with morphine paired with white side n=7). 
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The pattern of results for the rats that received morphine paired with the 
black side was very different. Figures 8 and 9 show the data for the F344 
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and the HIV-1Tg rats respectively. These were plotted in the same manner 
as the previous graphs. The Extinction 1 and 2 data were analysed 
separately with a Strain (2) x Drug (2) x Days (8 or 9) mixed ANOVA. 
During the first 5 minutes of Extinction 1 there was a significant preference 
for the morphine-paired side that persisted across days of Extinction 1 in 
both strains [Main Effect of Drug: F(1.12) =6.32, P =.027; Drug x Days: 
F(7.84) < 1. n.s.]. There were no significant effects of strain. By Extinction 
2 the main effect of Drug was no longer significant [F (1,12) < 1. n.s.]· 
indicating the extinction of a CPP. Once again there were no significant 
effects of strain. 
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__ 
Figure 8: The time spent in the morphine- and saline-paired sides over days of the 
F344 animals that received morphine paired with the black side. The Extinction 1 
graphs are shown on the left side and Extinction 2 are shown on the right. Data 
from only 2 of the 6 time segments are shown. The top graphs show the first time 
segment (minutes 1 - 5) and the lower graphs show the fourth time segment 
(minutes 16-20). During Extinction 2 the 16-20 minute time segment was preceded 
by a break from the previous session to allow for spontaneous recovery of 
exploratory behavior. (F344 rats with morphine-paired with black side n=7) 
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During the fourth time segment (minutes 16-20) a reversal in preference 
from the black morphine-paired side to the white saline-paired side took 
place during Extinction 2 in the F344 rats (Figure 8) [F(7, 49) =2.41, p = 
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.034]. The absence of a significant preference during the 16-20 minute time 
segment of Extinction 1 may reflect the persistence of a conditioned 
preference for the black chamber that competed with the natural preference 
for the white chamber. By extinction 2 the extinguished CPP no longer 
competed with the natural preference, reversing the side preference. This 
reversal during minutes 16 - 20 in Extinction 2 was not observed in the 
HIV-'ITg rats [F(7,35) < 1, n.s.] (Figure 9), however, suggesting that CPP 
was not fully extinguished in the HIV-1Tg rats. Thus, the HIV-1Tg rats were 
tested for 3 additional days for extinction. 
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Figure 9: The time spent in the morphine- and saline-paired sides over days of the 
HIV-1Tg animals that received morphine paired with the black side. The Extinction 1 
graphs are shown on the left side and Extinction 2 are shown on the right. Data 
from only 2 of the 6 time segments are shown. The top graphs show the first time 
segment (minutes 1 - 5) and the lower graphs show the fourth time segment 
(minutes 16-20). During Extinction 2 the 16-20 minute time segment was preceded 
by a break from the previous session to allow for spontaneous recovery of 
exploratory behavior. (HIV-1Tg rats with morphine paired with black side n=7). 
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Figure 10 shows the results of the last three extinction days for the 
HIV-1Tg rats. There was no effect of days; therefore the means across all 
three days were presented. A Significant four-way interaction was found 
F(4,48) =3.39, P =.016. The rats for whom morphine was paired with the 
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white side (top graph) continued to show a significant preference for the 
morphine-paired side at all time segments and the preference increased 
across the first session as well as across the second session after 
spontaneous recovery of exploratory behaviour. The rats for whom 
morphine was paired with the black side (lower graph) did not show a 
preference during the first time segments of both extinction sessions (time 
segments 1-5 and 16-20) but showed a reverse preference in the 
subsequent sessions. Thus, although a reverse preference was not 
observed in the first five minutes of extinction like in the F344 rats, the 
strong preference for the saline-paired side later in the sessions is 
consistent with the suggestion that the white chamber is a highly preferred 
chamber that was not evident in preconditioning test. 
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Figure 10 - Time in Morphine-paired chamber over time segments for HIV-1Tg rats 
given three additional days of extinction during the second extinction p~ase (Mean 
of Days 18-20). (HIV-1Tg rats with morphine paired with white side n=7; (HIV-1Tg rats 
with morphine paired with black side n=7).). 
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Reinstatement with re-introduction o/morphine 
F344 (n=7) and HIV-1Tg (n=7) after reaching the extinction state were 
given 1 mg/kg morphine and tested for CPP by giving them free access to 
the entire apparatus for 15 minutes. On the next day the same animals 
were given a higher dose of morphine (3.5 mg/kg, Lp.) and then free access 
to the entire apparatus for 15 minutes. The HIV-1Tg and F344 animals that 
had morphine paired with the black side showed a preference for the saline­
paired side during the reinstatement test. This supports the argument that 
the rats had a natural preference for the white side that was counteracted 
by the CPP, but when the CPP is extinguished the animals chose to spend 
more time on the white side during all three time segments despite the 
reinstatement attempt. The data from the HIV-1Tg and F344 rats that had 
the morphine paired with the white side simply confirms that they had a 
preference for the white side. It cannot be assumed that this preference is 
a reinstatement effect because they never extinguished this preference 
during the extinction phase. 
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Reinstatement with a foot shock stressor. 
After reaching extinction the F344 (n=7) and HIV-1Tg (n=7) were 
administered a foot-shock for 15 min. intermittently and the tested for CPP 
by giving them free access to the entire apparatus for 15 min. The F344 
and HIV-1Tg rats that had the morphine paired with the white side showed 
a preference for the white chamber that increases across the time 
segments (Tim Seg x Drug: F344, F(2,4) = 29.245, = .004; HIV-1Tg, F(2, 6) 
= 7.773, P =.022). These groups, of course, cannot be used to assess 
reinstatement because their preference for white never extinguished, but it 
does confirm that the white preference in the white-morphine paired groups 
observed throughout extinction is still present. However, no statistically 
significant effects were observed in the F344 or HIV-1Tg rats that had 
morphine paired with the black side. 
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Discussion 
Endotoxin tolerance (ET) is a phenomenon in which previous exposure of 
cells or organisms to microbial products, such as the endotoxin, LPS, 
induces a transient period of hypo-responsiveness to a subsequent 
endotoxin challenge. Exposure to an endotoxin initiates the production of 
pro-inflammatory cytokines and a subsequent production of anti­
inflammatory cytokines by immune cells (Foster, Hargreaves et a!. 2007; 
Mages, Dietrich et a!. 2007; del Fresno, Garcia-Rio et al. 2009; Draisma, 
Pickkers et al. 2009). ET is characterized by diminished release of pro­
inflammatory cytokines, such as IL-1J3, IL-10, and TNF-a, and increased 
expression of anti-inflammatory cytokines, such as IL-10 (Biswas, Bist et al. 
2007). This negative feedback mechanism is important for protecting the 
host from tissue damage and death caused by excessive inflammation. 
The differential expression of cytokines/chemokines in different tissues and 
at different times has been examined in Sprague Dawley rats to investigate 
the modulation of immune responses (Chen, Zhou et al. 2005). 
The occurrence of ET has been shown to increase the incidence of 
several diseases, including sepsis, pancreatitis, trauma and surgery 
(Biswas and Lopez-Collazo 2009). The CDC has identified the increase of 
HIV-1 positive population as a major factor in the increased incidence of 
sepsis(Angus, Linde-Zwirble et al. 2001). Studies have shown that the 
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presence of HIV viral proteins causes a compromised immune response in 
HIV-1 patients (Capobianchi 1996; Schols and De Clercq 1996; Wilson, 
Habeshaw et al. 1997; Herbeuval and Shearer 2006; Boasso, Shearer et al. 
2009). The phenomenon of ET during HIV-1 infection has not been 
studied through animal models. Reid and colleagues (Reid, Sadowska et 
al. 2001) established a non-infectious HIV-1 transgenic (HIV-1Tg) rat model 
that expresses an HIV-1 provirus regulated by the viral promoter, but with a 
functional deletion of gag and pol. The characteristics of the HIV-1Tg rat 
include immunologic dysfunction, nephropathy, muscle wasting, skin 
lesions, and cataracts. We studied the systemic effect of the concurrent 
presence HIV-1 viral proteins and ET on the inflammatory response to 
bacterial endotoxin using the HIV-1Tg rat model. We examined the LPS­
induced gene expression of 84 cytokines, chemokines, and their receptors 
in the blood, brain, and spleen of the endotoxin tolerant HIV-1Tg rat. Based 
on previous studies, we used two injections of a low dose of LPS (250 
IJg/kg) administered 9 h apart to induce ET, and a challenge injection with a 
high dose of LPS (5 mg/kg) 12 h later. A single exposure to a high dose of 
endotoxin should cause a significant increase in the levels of pro­
innammatory and anti-inflammatory cytokines compared to control (Chen, 
Zhou et al. 2005). In the ET state, when animals are exposed to repeated 
low doses of endotoxin, upon a subsequent challenge with a high dose of 
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the endotoxin, one would expect that the increase in the pro-inflammatory 
cytokine levels would be lower compared to that in the single high dose 
exposure group (Biswas, Bist et al. 2007). To confirm that the animals 
were in the ET state, we measured the protein levels of inflammatory 
cytokines after the LPS challenge dose. Although the basal levels in the 
brain, spleen, and serum of the control groups (SS+S) of F344 and HIV-1Tg 
rats were similar, the changes in the cytokine and chemokine profiles in 
response to LPS were different in the HIV-1Tg and F344 rats. We found 
that, during ET, there was a significantly diminished expression of pro­
inflammatory cytokines, such as IL-1~, IFN-y, and TNF-a, in response to 
LPS (LL +L) compared to a single exposure of LPS (SS+L). 
Of particular interest was the finding that the basal level of IFN-y in the 
spleen was lower in the SS+S group of HIV-1Tg rats than of the F344 rats, 
but was significantly increased in the SS+L and LL +L groups of the HIV-1 T g 
rats compared to the F344 rats (Table 3). A recent study showed that IFN-y 
countered ET by facilitating Toll-like receptor (TLR)-induced chromatin 
remodeling (Chen and Ivashkiv 2010). ET was prevented in IFN-y pre­
treated primary human monocytes, and production of pro-inflammatory 
cytokines, such as TNF-a and IL-6, was restored by facilitating TLR-induced 
chromatin remodeling (Chen and Ivashkiv 2010). It would be interesting to 
examine what role IFN-y plays in the restoration of the production of pro­
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inflammatory cytokines at the transcriptional level in the HIV-1Tg rat 
compared to control. 
We found that, in both the ET state and after a single exposure to LPS. 
there was an altered response to LPS in terms of pro-inflammatory cytokine 
production in the spleen of the HIV-1Tg rats compared to the F344 rats. 
The expression level of the pro-inflammatory cytokines, IL-1a, IL-1 J3, and 
IFN-y, was 4- to 82-fold greater in the spleen of the HIV-1Tg rats compared 
to the F344 rats in both the single LPS exposure (SS+L) and ET (LL+L) 
groups, indicating that the presence of viral proteins may have an effect on 
innate immune responses. There was also a difference in the expression of 
cytokine receptors in the brain of the HIV-1Tg rats compared to the F344 
rats in response to LPS in both the ET state and after a single exposure to 
LPS, suggesting that HIV-1 viral proteins may interact with or work through 
cytokine receptors in the brain. These data warrant further investigation 
into the neuroimmune effects of HIV-1 viral proteins. 
Studies show that there is an alteration of cytokine receptors in the brain 
during HIV infection(Masliah, Ge et al. 1994) and that there is an 
association of IL2Ralpha, IL4Ralpha, IL 10Ralpha, and IFN (gamma) R1 
cytokine receptor genes with AIDS progression(Do, Vasilescu et al. 2006) 
and that cytokine receptor deficiencies may contribute to immune deficiency 
in HIV-infected patients (Pahwa 2007). Sirskyj D and colleagues 
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comprehensively review the effects of the disruption of the 
cytokine/cytokine receptor network in T -cells during HIV infection(Sirskyj, 
Theze et al. 2008). However, the molecular mechanisms causing this are 
largely unknown, due to the due to the incredibly complex interplay between 
viral factors and host cytokine signaling pathways (Sirskyj, Theze et al. 
2008). 
During ET, the production of pro-inflammatory cytokines, such as IL-1J3, 
IL-4, and IL-5, in response to LPS (LL +L) was diminished in contrast to that 
elicited by a single exposure to the endotoxin (SS+L). This altered 
response was seen in the spleen and serum in both the HIV-1Tg and F344 
ET rats. 
The spleen is an immune system organ, and, as such, one would expect 
that a greater number of cytokine and chemokine genes would be changed 
in the spleen in response to an immune challenge compared to the brain, 
and that is what we found in this study. In both the HIV-1Tg and F344 rats, 
there was a greater response to LPS in the spleen than in the brain. 
Chemokines and their receptors have been implicated in the 
neuropathogenesis of HIV-1 infection (Mahajan, Schwartz et al. 2002). 
There were significant differences in chemokine expression in response to 
LPS in the HIV-1Tg rats compared to the F344 rats. Enhanced levels of 
Ccl2 in HIV-1 patients have been associated with HIV-1-associated 
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dementia (Ansari, Heiken et al. 2007). Our results indicate that Ccl2 levels 
were increased to a greater extent (3- to 5-fold) in the brain of the SS+L 
and LL+L groups of HIV-1Tg rats versus the F344 rats, corroborating the 
role of upregulation of Ccl2 and its implications on HIVencephalopathy. 
The levels of the inflammatory CXC chemokines, Cxcl1, Cxcl2, Cxcl10, and 
Cxcl11, were elevated to a greater extent (0.1- to 40-fold) in the brain of the 
SS+L and LL+L groups of the F344 rats compared to the HIV-1Tg rats. 
Ccl2, Ccl7, and Ccl9,levels were increased to a greater extent in the SS+L 
and LL +L groups of the spleen of the HIV-1 Tg rats in comparison to the 
F344 rats. Cxcl1 and Cxcl2 levels were elevated to a lesser extent in the 
spleen of the SS+L and LL +L groups of the F344 rats compared to the HIV­
1Tg rats. 
Chemokines and chemokine receptors define a network throughout the 
body, playing critical roles in immune and inflammatory responses as well 
as in many pathological processes, in diseases such as multiple sclerosis, 
Alzheimer's disease, and HIV/AIDS (Martin-Garcia, Kolson et al. 2002). 
Cxcr4 and Ccr5 are reported to be co-receptors that mediate HIV-1 entry 
(8achis, Cruz et al. 2010). In our study, the gene expression of the 
chemokine receptors, Ccr2, Ccr3, Ccr4, Ccr5, Ccr7, Cxcr3, Ccr10, Ccr3, 
Cx3cr1, IL-BrJ3, and Xcr1, in the spleen of the ET group (LL +L) of F344 rats 
were down-regulated, whereas those in the HIV-1Tg spleen were not 
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significantly different compared to the control group (SS+S). All these 
receptors have been shown to function as co-receptors for HIV-1infection 
in vitro (Starr-Spires and Collman 2002), which suggests that HIV-1 viral 
proteins may interact with these chemokine receptors in vivo. There is also 
evidence that chemokines and chemokine receptors play an important part 
in the signaling of neuroprotective effects in the brain (Martin-Garcia, 
Kolson et al. 2002). 
In this study, we noted a distinct pattern of cytokine/chemokine 
expression in the brain. spleen. and serum of the HIV-1Tg and F344 rats in 
response to LPS, both with and without ET. Identifying these distinct 
cytokine/chemokine profiles may potentially be useful as indicators of the 
onset and/or progression of certain disease processes, such as sepsis. 
Further studies will be done to determine the relationship of viral protein 
expression to the production of cytokines and chemokines during ET. 
In our other study of CPP in the HIV-1Tg and control F344 animals, we 
explored the hypothesis that the HIV-1Tg rat is more prone to the addictive 
properties of morphine than the control animal F344 because expression of 
MOR is up-regulated in the HIV-1Tg rat (Chang. Beltran et al. 2007). We 
used the CPP test to measure the motivational salience of morphine paired 
cues of the HIV-1Tg rats versus control, F344 rats. A dose of 3.5mglkg 
morphine successfully established a CPP in both the HIV-1Tg and F344 
88 

rats. However, an unanticipated finding was that rats that had morphine 
paired with the white chamber failed to show any evidence of extinction, 
whereas the rats that had morphine paired with the black chamber showed 
successful extinction and the emergence of a reversed preference. When 
the color of the morphine-paired chamber was not taken into consideration 
in the statistical analysis, group averages suggested that extinction 
occurred after 17 and 20 days for F344 and HIV-1Tg rats, respectively. 
o However, when the morphine-paired chamber was included as a factor in 
the analysis, it was revealed that extinction occurred earlier in the rats for 
whom morphine was paired with the black chamber, but not in the rats for 
whom morphine was paired with the white chamber. 
During a CPP test rats freely explore both sides of the apparatus, spending 
more time overall on the morphine-paired side if a CPP is established. The 
behavior of the rats in a CPP apparatus, however, is affected by factors 
other than a CPP that are not typically assessed systematically in CPP 
studies. When first placed in the apparatus the relative novelty of the 
environment activates exploratory behavior that declines or habituates over 
time. As exploratory behavior undergoes habituation the rats move less 
and choose to settle in a preferred chamber if a preference is present 
(Reid, Marglin et al. 1989). Rats may settle in one chamber because that 
chamber accrued rewarding properties when it was paired with morphine; 
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this is basic assumption of the CPP test. However, our present studies 
suggest that following habituation of exploratory behavior rats may also 
settle to one chamber when a natural preference for that chamber exists 
that may not have been apparent in the preconditioning phase when the 
novelty of the apparatus was activating high levels of exploratory behavior. 
The presence or absence of natural preferences is a characteristic of the 
CPP apparatus that has been considered in the literature. When morphine 
is paired with the naturally preferred chamber, the observed CPP is 
assumed to result from the sum of the natural preference and the 
conditioned preference. When morphine is paired with the non-preferred 
chamber, however, the conditioned rewarding properties of the previously 
less preferred chamber will compete with the naturally preferred chamber. 
If the newly acquired rewarding properties are sufficiently strong to compete 
successfully with the natural preference a CPP will be observed, although it 
is likely to be weaker than in subjects that had morphine paired with the 
naturally preferred side. This is the reason that the drug is paired with the 
non-preferred side when a biased CPP apparatus is used (Roma and Riley 
2005). A successful CPP in a biased apparatus indicates that the 
conditioned rewarding properties were sufficiently strong to overcome the 
natural preference. With an unbiased apparatus the drug is not paired with 
a preferred side although the drug-paired chamber is typically 
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counterbalanced within groups. But the results of the present study 
suggest that natural chamber preferences may not be apparent when a 
single brief preconditioning test that is a common procedure as suggested 
in the CPP literature is used. This is because that there is not sufficient 
opportunity for the habituation of intense exploratory behavior to reveal the 
natural preference When we analyzed the pre-conditioning and post­
conditioning results separated into three 5-minute time segments no 
statistically significant side preference was observed during preconditioning 
in the two-chamber CPP apparatus used in the present experiment. 
However, the post-conditioning data showed clear changes in preference 
over the three 5-minute periods. As time passed rats generally explored 
less and spent more time in the morphine-paired chamber. This pattern 
was most pronounced in the rats that experienced morphine paired with the 
white chamber. 
There were animals that did not extinguish the morphine-induced CPP and 
there were other animals that did show extinction. For clarity these are 
discussed separately below. 
Failed Extinction ofa CPP 
The extinction data indicated that the preference for the white morphine­
paired side failed to weaken despite 17 (F344 rats) and 20 (HIV-1Tg rats) 
days of exposure to the extinction procedure. Moreover, within-session 
91 

increases in preference for the morphine-paired side was consistently 
observed in the white-morphine paired rats, but not in the black-morphine 
paired rats. We argue that the within-session increase in preference is due 
to habituation of exploratory behavior. Evidence consistent with this 
habituation interpretation is provided in Extinction 2 where spontaneous 
recovery of exploratory behavior was observed as a result of the delay 
between Extinction 2a and 2b. Our studies also show that the rats had a 
natural preference for the white chamber that was not evident in the 
preconditioning phase, but when paired with morphine this preference 
became more evident. The natural place preference plus the conditioned 
place preference may have synergized to augment the preference for the 
white side. An alternative explanation is that morphine enhanced the 
natural preference without inducing a CPP as it is typically characterized. 
If the increased preference for the white chamber was due to the summing 
of a natural preference and a CPP, then repeated exposure to the chamber 
cues in the absence of morphine treatment should decrease the place 
preference as the CPP undergoes extinction, but there was no evidence of 
extinction in the white-morphine paired groups. It cannot be ruled out that 
extinction would have been observed if additional extinction days were 
given. However, the expectation of an increased likelihood of extinction 
given sufficient extinction trials is based on the prevailing theoretical view 
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that explains CPP as a case of classical conditioning that involves 
predictive learning. Alternatively. the CPP procedure with morphine may 
result in another form of behavioral plasticity that does not conform to a 
predictive learning account of classical conditioning. 
In the predictive learning model of classical conditioning the acquisition of 
CPP is seen as involving an association between the discriminative 
chamber cues and the rewarding properties of morphine. such that the 
chamber cues predict the availability of morphine. In the extinction 
procedure a new association is presumed to occur (i.e .• the chamber cues 
no longer predict the availability of morphine) that supersedes the original 
association, causing CPP to extinguish. When the rats are "reminded" of 
the earlier predictive relationship in a reinstatement procedure the CPP 
reemerges; that is. the morphine effect is once again anticipated. However. 
there are several well documented cases of classical conditioning 
procedures that result in a conditioned preference that do not extinguish. 
When the consumption of a flavored saccharin solution is paired with a 
carbohydrate solution that is pumped directly into the stomach, for example, 
rats develop a strong preference for the flavored saccharin solution that is 
highly resistant to extinction(Elizalde and Sclafani 1990; Drucker, Ackroff et 
al. 1994). This suggests that some preferences that are established with 
classical conditioning procedures may not be easily eliminated by 
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extinction. A body of research has found similar effects in animals and 
humans and is referred to as evaluative conditioning (Baeyens and De 
Houwer 1995; De Houwer, Thomas et al. 2001). In evaluative conditioning 
the positive value of the unconditioned stimilus is presumed to transfer to 
the conditioned stimulus, increasing the liking of the CS. Therefore, the 
positive value of the morphine US in the present study may have been 
transferred to preferential discriminative chamber cues (white chamber) to 
produce an enhanced preference that is highly resistant to extinction. 
Indeed a persistent preference for cues previously paired with a 
psychoactive drug would help explain an individual's life-time struggle with 
drug addiction - the acquired preference for drug-paired cues never really 
go away. Interestingly, numerous studies show that conditioned responses 
to drug-paired cues can undergo extinction in animals, but the evidence of 
similar extinction effects in humans is lacking (Myers and Carlezon 2010). 
It is unclear what factors may be involved in whether a CPP undergoes 
extinction or whether it persists indefinitely. One possible factor that may 
influence resistance to extinction may be the type of morphine-paired cue. 
A CPP that resists extinction may be more likely if there is a natural 
preference for the paired cue before conditioning, even if the natural 
preference is not immediately apparent early in testing because other 
behaviors (e. g., exploratory behavior) mask the initial preference. Clearly 
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not all preferred cues paired with a drug lead to CPP that fails to extinguish 
since extinction is often observed in biased CPP procedures where the drug 
is paired with an initially preferred side. An enhanced natural preference 
may be most prominant when morphine is paired with contact cues (that is, 
floor cues) because once rats make physical contact with the floor cues 
they may prefer to maintain contact with these cues and reduce their 
approach to other distal cues (Vezina and Stewart 1987). 
The prevalence of CPP that is highly resistant to extinct is not well known. 
Investigators often do not test for extinction of CPP because it is not 
germane to the hypothesis being investigated. When extinction is a desired 
outcome in an experiment (e.g., to test for reinstatement, for example) any 
procedure that results in CPP that resists extinction may be interpreted as a 
failed procedure and abandoned in favor of procedures that yield CPP 
results more consistent with a predictive memory model interpretation. 
Nevertheless there are several examples of high resistance to extinction of 
morphine-induced CPP in the literature. Most recently, for example, Rutten 
and colleagues reported that it took 18 fifteen-min ute-sessions to see 
extinction of a 3.0 mg/kg dose and up to 45 fifteen-minute-sessions for a 10 
mg/kg dose of morphine (Rutten K 2011). In another recent study, Narp 
knockout mice failed to extinguish a morphine CPP. The authors conclude 
that the Narp deletion disrupts the ability to update the predictive 
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association between the CPP context cues and the drug reward (Crombag, 
Dickson et al. 2009). However, this conclusion assumes that morphine 
CPP procedures result in associative predictive learning. If CPP can also 
result in the establishment of long lasting preference that is not 
subsequently altered through extinction, then it is difficult to determine if 
Narp deletion failed the updating of predictive learning (failed extinction) or 
if it resulted in an enhanced behavioural plasticity that is better described as 
evaluative conditioning. It is also possible that a preference for floor cues 
may have been altered in the transgenic mice, rather than their propensity 
to learn, and morphine induced an enhancement of this altered, natural 
preference. We suggest here that the interpretation of extinction 
performance of morphine CPP may be complicated by the behavioural 
plasticity noted in the present CPP experiment and a more detailed analysis 
of changing preferences across CPP sessions can help evaluate the factors 
that contribute to the acquisition and maintenance of a place preference. 
It is still plausible that a CPP was established along with an enhanced 
natural preference in the white morphine paired animals, but the natural 
preference dominated over the CPP. Thus, we examined place preference 
early in an extinction session (minutes 1 -5), when the animals are 
exploring at their maximum because habituation has not yet occurred. The 
exploratory behavior early in the session may be guided primarily by the 
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morphine predicitve cues (Le., CPP) independent of a natural preference. 
The same can be said for minutes 16 -20 in Extinction 2b, because the 
delay allowed the spontaneous recovery of exploratory behavior in this time 
segment. 
A preference for the morphine-paired side in the first 5 minutes was 
observed that did not decrease over days in Extinction 1 or Extinction 2. 
Thus, there was no evidence of extinction of morphine-pridictive cues over 
days, even when just the first 5 minutes are examined. By the fourth time 
segment (minutes 16-20) of Extinction 1 the preference for the morphine­
paired time was even greater as exploratory behavior was habituating, but 
during Extinction 2 the preference is again reduced as exploratory behavior 
spontaneously recovers. Yet there is still no indication of a decreased 
preference for the morphine-paired side over days. The same pattern was 
also seen in the HIV-1Tg rats. The evidence suggests, therefore, that 
morphine induced enhanced natural preference when it was paired with the 
white chamber rather than a CPP. Perhaps this enhanced natural 
preference is best described as a type of evaluative conditioning (Baeyens 
and De Houwer 1995; De Houwer, Thomas et al. 2001). A limitation of the 
evaluation conditioning hypotheSiS is that a control group that received no 
morphine treatment but similar number of "extinction" exposures to the 
chamber was not available to assess the strength of the natural preference 
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in the absence of morphine. Nevertheless, the evaluative conditioning 
hypothesis is worth exploring given the many cases in the literature of 
preferences that are highly resistant to extinction. 
Extinction ofa CPP 
The same analysis of the data over time segments from the black-morphine 
paired groups yielded evidence of the extinction of a CPP. The evidence 
suggests that these groups established a CPP that overcame the natural 
preference for the white chamber and that this CPP extinguished. Although 
the black-morphine paired groups did not experience an enhancement of 
the natural preference for the white chamber (because it was not paired 
with morphine) the hypothesized natural preference for the white side 
should still be present. As extinction of the CPP occurs the natural 
preference for the white side should emerge. This is what was observed. 
During the first 5 minutes of Extinction 1 there was a significant preference 
for the morphine-paired side that persisted across days of Extinction 1 in 
both the F344 and HIV-1Tg groups. By Extinction 2 the main effect of drug 
was no longer evident, indicating that the CPP had extinguished. 
During the fourth time segment (minutes 16-20) of Extinction 2a significant 
reversal in preference from the black morphine-paired chamber to the white 
saline-paired chamber was observed in the F344 rats. This preference 
reversal from the black morphine-paired chamber to the white saline-paired 
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chamber during minutes 16 - 20 in Extinction 2 was not observed in the 
HIV-1Tg rats, however, suggesting that CPP was not fully extinguished in 
the HIV-1Tg rats. An additional 3 days of extinction for the HIV-1Tg rats still 
failed to result in a reverse preference during the first 5 minutes of the 
extinction sessions, but the reverse preference was clearly evident in the 
last 10 minutes of the extinction sessions. 
The lack of preference reversal in the HIV-1Tg rats during the first 5 
minutes of extinction suggests that the HIV-1Tg rats showed greater 
resistance to extinction of a CPP than the F344 rats. A more substantial 
resistance to extinction was observed in the HIV-1Tg rats in a previous 
study (Chang and Connaghan 2011). nevertheless both studies support the 
hypothesis that morphine has a greater rewarding efficacy in the HIV-1Tg 
rats (Rutten K 2011). The difference in the magnitude of the resistance to 
extinction that was observed between the two studies is most likely due to 
the apparatus used. In the previous study a custom-made three­
compartment apparatus was used that resulted in a very strong natural 
preference for the smaller middle compartment. Many rats also showed a 
slight preference for one of the two larger compartments. Morphine was 
paired with the less preferred of the two larger chambers while saline was 
paired with the other large chamber. The middle chamber was not paired 
with any injection. To assess CPP the time in the two larger chambers 
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were compared while the time in the middle chamber was not taken into 
consideration. The rats spent most of their time in the naturally preferred 
chamber, but when the times in the two larger chambers were compared a 
significant CPP was observed that took significantly longer to extinguish in 
the HIV-1Tg rats. Thus, in the previous study with a three-compartment 
chamber the strong natural preference for the smaller chamber did not 
compete directly with the CPP that was established in the larger chambers, 
whereas in the current study with the two-compartment apparatus the 
natural preference competed with the CPP. When morphine was paired 
directly with the naturally preferred white chamber in the present study. the 
preference was enhanced to be greater than rats that did not experience 
morphine paired with their naturally preferred chamber. 
Reinstatement of Cpp 
A salient feature of drug addiction is relapse (Koob and Nestler 1997; 
Kalivas and Volkow 2005). Even after long drug-free periods the subject 
can relapse to drug seeking and use if exposed to small quantities of the 
drug, to a drug-paired cue or to stress (O'Brien 1997; Kalivas and Volkow 
2005). CPP has been used to measure reinstatement for extinguished 
place preference by reintroduction of the drug (drug-priming) or to stressors 
(Wang, Luo et al. 2000; Shaham, Shalev et al. 2003; Aguilar, Rodriguez­
Arias et al. 2009; Chang 2010; Chang 2011 ). 
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In the present experiment, we used morphine primes of 1 mg/kg and 3.5 
mg/kg in the HIV-1Tg and F344 rats for whom the morphine-induced CPP 
was extinguished. The HIV-1Tg and F344 rats paired with the white and 
black chamber did not show re-instatement of CPP at either dose of 
morphine. The HIV-1Tg and F344 rats for whom morphine was paired with 
the black chamber, preferred the saline-paired side during the 
reinstatement test. This supports the argument that the rats had a natural 
preference for the white side that was counteracted by the CPP, but now 
that the CPP is extinguished they are choosing to spend more time on the 
white side during all three time periods despite the reinstatement attempt. It 
may be that this white side preference was overcome by the initial CPP, but 
the reinstatement effect was just not strong enough to overcome this 
natural preference. 
There is considerable research indicating that there are major differences in 
the neurocircuitry and neurobiology of reinstatement by drug-priming, by 
cues and by stressors (Shaham, Shalev et al. 2003; Bossert, Ghitza et al. 
2005). Stewart and colleagues show that the corticotrophin-releasing factor 
and noradrenergic dependent pathways were primarily involved in foot­
shock stress induced relapse but had little effect on drug-induced relapse 
(Shaham, Erb et al. 2000; Stewart 2000; Erb S 2001; Stewart 2003). There 
are studies which indicate that stress is a co-risk-factor in the drug-addiction 
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relapse in the HIV-1 positive population (Demas, Schoenbaum et al. 1995; 
Rotheram-Borus, Rosario et al. 1995; Back, Dansky et al. 2001; Tull, 
Trotman et al. 2009). Under foot shock stress the F344 and HIV-1Tg rats 
that had the morphine paired with the white side continued to show a 
preference for the white side. However, no statistically significant effects 
were observed in the F344 or HIV-1Tg rats that had morphine paired with 
the black side. This result may suggest that the stress reinstated a CPP 
sufficient enough to counteract the preference for white, but not enough to 
reverse the preference for the morphine-paired side. An alternative 
explanation is that the black-morphine paired animals were showing a 
smaller preference for the white side by the end of extinction (the natural 
white side preference was not enhanced for them because it was never 
paired with morphine) and in these reinstatement tests the smaller 
preference is no longer evident because of the reduced statistical power as 
a result of reducing the number of subjects by about half. 
The failure to observe reinstatement effects in this experiment precluded 
the test of the hypothesis that HIV-1Tg and F344 rats differ in their 
sensitivity to morphine. There was some evidence, however, that the HIV­
1Tg rats display a greater resistance to extinction of a morphine CPP; a 
result that is consistent with a previous experiment using a three­
compartment biased CPP apparatus (Chang 2011). These differences in 
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resistance to extinction of a morphine CPP supports the hypothesis that 
viral proteins alters the effects of morphine on behaviour, but more studies 
and a better understanding of the behavioural plasticity that occurs in the 
morphine CPP procedure is needed before these effects of viral proteins 
can be elucidated. 
Conclusions andFuture Direction 
The data from our study endotoxin -induced cytokine chemokine-profile in 
the HIV-1Tg and control F344 animals provides a comprehensive picture of 
the neuroimmune responses to infection during ET, and strongly suggest 
that the presence of HIV-1 viral proteins may exacerbate those responses. 
These findings also suggest the potential use of experimentally defined 
cytokine/chemokine expression profiles as indicators of altered immune 
function in various disease states. 
Our results of the CPP study in HIV-1Tg rats failed to show reinstatement 
however the HIV-1 Tg rats did take a longer time to extinguish the morphine­
induced CPP, which supports our hypothesis that the persistent presence of 
viral proteins may lead to an increased propensity for morphine induced 
motivational salience. Moreover, this data suggested that the CPP 
procedure itself may result in a behavioural plasticity that does not conform 
to the Pavlovian/memory model. 
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IFuture studies 
Our study of endotoxin-induced cytokine- and chemokine-profiles in the 
HIV-1 T g, provided valuable information of the specific inflammatory 
cytokine, chemokine and their receptors' genes that were modulated during 
ET in the HIV-1Tg rat, it would be interesting to study the protein levels of 
these modulated genes: 
• 	 IL-1a, IL-1j3, and IFN-y in the spleen as these genes were 4- to 82­
fold greater in the spleen of the HIV-1Tg rats compared to the F344 
rats in both the single LPS exposure (SS+L) and ET (LL +L) 
• 	 Cytokine receptors -IL-1 r2, IL-2rj3, IL-2ry, IL-5ra, IL-6ra, IL-6st. in 
the brain as these were differently modulated in the brains of the 
HIV-1Tg rats compared to the F344 rats in response to LPS in both 
the ET state and after a single exposure to LPS 
• 	 In the brain, Ccl2, Cxcl1, Cxcl2, Cxcl10, and Cxcl11, which were 
levels, which differently modulated in the brains ofthe HIV-1Tg rats 
compared to the F344 rats in response to LPS in both the ET state 
and after a single exposure to LPS 
• 	 In the spleen, Cc12, Cc17, Cc19, Cxcl1 and Cxcl2 levels 
• 	 Ccr2, Ccr3. Ccr4, Ccr5. Ccr7, Cxcr3, Ccr10, Ccr3, Cx3cr1, IL-8rj3, 
and Xcr1, in the spleen 
104 
MOR is upregulated in the HIV-1Tg rat and we hypothesize that this may 
have lead to the differences in the endotoxin-induced cytokine/chemokine 
profiles between the HIV-1Tg and control animals as MOR is known to 
modulate cytokine/chemokine networks. To explore the role of MOR in 
modulation of cytokine- chemokine networks during ET, it would be 
reasonable to study these cytokine/chemokine genes modulated in this 
study during ET in MOR knock out rats to compare with the results obtained 
with F344 rats in ET state in our study. 
Our morphine CPP study in HIV-1Tg rats has characterized this important 
HIV-1 model and provides novel and valuable information on morphine­
induced CPP, which may result in a behavioural plasticity that does not 
conform to the Pavlovian/memory model. 
In our morphine-induced CPP study we noted that for all animals their 
preference for the white chamber was enhanced by morphine, however, 
this preference was not initially noted in the pre-conditioning phase. A 
future study could explore if there is an initial preference of the animals for a 
particular chamber by way of a longer pre-conditioning phase (3-days). If a 
preference for the animals is observed in the pre-conditioning phase then a 
biased design (versus the balanced design) for establishing a CPP could be 
used where morphine is paired with the non-preferred chamber during the 
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conditioning phase. It would be interesting to explore if the "enhanced" 
preference for one of the chambers still develops in the animals after 
morphine-treatment using a biased design. Further if a morphine-induced 
CPP is successfully produced using the biased design it would be 
interesting to study the difference in the rate of extinction and in the 
reinstatement of a drug-induced and/or stress-induced CPP between the 
HIV-1Tg and control F344 rats. This will investigate our hypothesis that 
HIV-1Tg may be more prone to morphine addiction due to the upregulation 
of MOR in HIV-1Tg rats. 
It would be of interest to know if extinction would eventually happen the 
animals who had morphine paired with the white side and did not show 
extinction. But rather than give many more extinction trials, which may 
require weeks of extinction exposure, a more practical approach would be 
to reverse the conditions and retrain the animals but this time pair 
morphine with the black side chamber. This reverse pairing should change 
the preference as they learn that black is now associated with morphine 
(reversal and extinction are similar in that they both involve a new learning, 
but reversal learning should be faster because of the actual presence of 
morphine). Also, if it would let us explore if the HIV-1Tg rats do indeed 
learn more slowly, if any observed reversal of the preference is slower in 
the HIV-1Tg rats compared to the F344 rats. 
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